Document:

Exhibit 4.3

 

FORM OF

 

COMMON STOCK PURCHASE WARRANT

 

“THE SECURITIES EVIDENCED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY
BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY
SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, OR (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE
GOVERNMENTAL AUTHORITIES.

 

THE SECURITIES EVIDENCED ARE SUBJECT
TO A LOCKUP AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE LOCKUP.”

 

	September 27, 2019	No. ___

 

ONDAS HOLDINGS INC.

 

This certifies that,
for good and valuable consideration, receipt of which is hereby acknowledged, _______________ (“Holder”),
is entitled to purchase, subject to the terms and conditions of this Warrant, from Ondas Holdings Inc., a Nevada corporation (the
“Company”), _________________________ (______) fully paid and nonassessable shares of the
Company’s Common Stock, par value $0.0001 per share (“Common Stock”). Holder shall be entitled to
purchase the shares of Common Stock in accordance with Section 2 at any time during the Exercise Period (as defined below).
The shares of Common Stock of the Company for which this Warrant is exercisable, as adjusted from time to time pursuant to the
terms hereof, are hereinafter referred to as the “Shares.” This Warrant is issued pursuant to section 5
of that certain Revenue Loan Agreement by and between Holder and the Company, dated September 14, 2017.

 

1. Exercise Period;
Price.

 

1.1 Exercise
Period. This Warrant shall vest and become exercisable upon issuance and the exercise period (“Exercise Period”)
shall terminate at 5:00 p.m. Eastern Time on September 26, 2024 (the “Expiration Date”).

 

1.2 Exercise
Price. The initial purchase price for each of the Shares shall be $0.01 per share. Such price shall be subject to adjustment
pursuant to the terms hereof (such price, as adjusted from time to time, is hereinafter referred to as the “Exercise
Price”).

 

1.3 Vesting.
The shares of Common Stock that Holder is entitled to purchase hereunder shall vest immediately upon exercise by the Holder and
issuance by the Company.

 

2. Exercise and
Payment. 

 

2.1 As set forth herein,
this Warrant may be exercised, in whole or in part, from time to time by the Holder, during the Exercise Period, by surrender of
this Warrant and the Notice of Exercise attached hereto as Annex I, duly completed and executed by the Holder, to the Company
at the principal executive offices of the Company, together with payment in the amount obtained by multiplying the Exercise Price
then in effect by the number of Shares thereby purchased, as designated in the Notice of Exercise. Payment may be in cash, wire
transfer or by check payable to the order of the Company in immediately available funds.

 

     

     

    

 

3. Reservation
of Shares. The Company hereby agrees that at all times there shall be reserved for issuance and delivery upon exercise
of this Warrant such number of shares of Common Stock or other shares of capital stock of the Company from time to time issuable
upon exercise of this Warrant. All such shares shall be duly authorized, and when issued upon such exercise, shall be validly issued,
fully paid and non-assessable, free and clear of all liens, security interests, charges and other encumbrances or restrictions
on sale and free and clear of all preemptive rights.

 

4. Delivery of
Stock Certificates. Within three (3) trading days after exercise, in whole or in part, of this Warrant, the Company shall
issue in the name of and deliver to the Holder a certificate or certificates for the number of fully paid and nonassessable Shares
which the Holder shall have requested in the Notice of Exercise. If this Warrant is exercised in part, the Company shall deliver
to the Holder a new Warrant (dated the date hereof and of like tenor) for the unexercised portion of this Warrant at the time of
delivery of such stock certificate or certificates. In lieu of delivering physical certificates representing the Shares issuable
upon exercise of this Warrant, provided the Company is participating in the Depository Trust Company (“DTC”)
Fast Automated Securities Transfer (FAST) program, the Company may cause its transfer agent to electronically transmit the Shares
issuable upon exercise to the Holder by crediting the account of Holder’s Prime Broker with DTC through its Deposit Withdrawal
Agent Commission (DWAC) system.

 

5. No Fractional
Shares.  This Warrant must be exercised for a whole number of Shares. No fractional shares or scrip representing fractional
Shares will be issued upon exercise of this Warrant. Any fractional Share which otherwise might be issuable on the exercise of
this Warrant as a result of the adjustment provisions in Section 9 hereof will be rounded up to the nearest whole Share.

 

6. Charges, Taxes
and Expenses. The Company shall pay all transfer taxes or other incidental charges, if any, in connection with the transfer
of the Shares purchased pursuant to the exercise hereof from the Company to the Holder.

 

7. Loss, Theft,
Destruction or Mutilation of Warrant. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss,
theft, destruction or mutilation of this Warrant, and in case of loss, theft or destruction, of indemnity or security reasonably
satisfactory to the Company, and upon reimbursement to the Company of all reasonable expenses incidental thereto, and upon surrender
and cancellation of this Warrant, if mutilated, the Company will make and deliver a new Warrant of like tenor and dated as of such
cancellation, in lieu of this Warrant.

 

8. Saturdays, Sundays,
Holidays. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised
on the next succeeding weekday which is not a legal holiday.

 

    2

     

    

 

9. Adjustment of
Exercise Price and Number of Shares. The Exercise Price and the number of and kind of securities purchasable upon exercise
of this Warrant shall be subject to adjustment from time to time as follows:

 

(a) Adjustments
for Stock Splits and Combinations. If the Company shall at any time or from time to time after the date of this Warrant,
effect a stock split of the outstanding Common Stock, the applicable Exercise Price in effect immediately prior to the stock split
shall be proportionately decreased. If the Holder shall at any time or from time to time after the date of this Warrant, combine
the outstanding shares of Common Stock, the applicable Exercise Price in effect immediately prior to the combination shall be proportionately
increased. Any adjustments under this Section 9(a) shall be effective at the close of business on the date the stock split or combination
occurs.

 

(b) Adjustments
for Certain Dividends and Distributions. If the Company shall at any time or from time to time after the date of this Warrant,
make or issue or set a record date for the determination of holders of Common Stock entitled to receive a dividend or other distribution
payable in shares of Common Stock then, and in each event, the applicable Exercise Price in effect immediately prior to such event
shall be decreased as of the time of such issuance or, in the event such record date shall have been fixed, as of the close of
business on such record date, by multiplying, the applicable Exercise Price then in effect by a fraction:

 

(i) the numerator
of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance
or the close of business on such record date; and

 

(ii) the denominator
of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance
or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such dividend or
distribution.

 

(c) Adjustments
for Reclassification, Exchange or Substitution. If the Common Stock issuable upon exercise of this Warrant at any time
or from time to time after the date of this Warrant shall be changed to the same or different number of shares of any class or
classes of stock, whether by reclassification, exchange, substitution or otherwise (other than by way of a stock split or combination
of shares or stock dividends provided for in Section 9(a), or a reorganization, merger, consolidation, or sale of assets provided
for in Section 9(d)), then, and in each event, an appropriate revision to the Exercise Price shall be made and provisions shall
be made (by adjustments of the Exercise Price or otherwise) so that the Holder shall have the right thereafter to exercise this
Warrant into the kind and amount of shares of stock and other securities receivable upon reclassification, exchange, substitution
or other change, by holders of the number of shares of Common Stock into which such Warrant might have been exercised immediately
prior to such reclassification, exchange, substitution or other change, all subject to further adjustment as provided herein.

 

    3

     

    

 

(d) Adjustments
for Reorganization, Merger, Consolidation or Sales of Assets. If at any time or from time to time after the date of this
Warrant there shall be a capital reorganization of the Company (other than by way of a stock split or combination of shares or
stock dividends or distributions provided for in Section 9(a), or a reclassification, exchange or substitution of shares provided
for in Section 9(c )), or a merger or consolidation of the Company with or into another corporation where the holders of Company
outstanding voting securities prior to such merger or consolidation do not own over fifty percent (50%) of the outstanding voting
securities of the merged or consolidated entity, immediately after such merger or consolidation, or the sale of all or substantially
all of the Company’s properties or assets to any other person (an “Organic Change), then as a part of such Organic Change,
an appropriate revision to the Exercise Price shall be made and provision shalt be made (by adjustments of the Exercise Price or
otherwise) so that the Holder shalt have the right thereafter to exercise such Warrant into the kind and amount of shares of stock
and other securities or property of the Company or any successor corporation resulting from Organic Change into which such Warrant
might have been exercised immediately prior to such Organic Change.

 

10. Notice of Adjustments;
Notices. Whenever the Exercise Price or number of Shares purchasable hereunder shall be adjusted pursuant to Section
9 hereof, the Company shall execute and deliver to the Holder a certificate setting forth, in reasonable detail, the event
requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated and the Exercise Price
and number of and kind of securities purchasable hereunder after giving effect to such adjustment, and shall cause a copy of such
certificate to be mailed (by first class mail, postage prepaid) to the Holder.

 

11. Rights As Stockholder;
Notice to Holders. Nothing contained in this Warrant shall be construed as conferring upon the Holder or his or its transferees
the right to vote or to receive dividends or to consent or to receive notice as a shareholder in respect of any meeting of stockholders
for the election of directors of the Company or of any other matter, or any rights whatsoever as stockholders of the Company. The
Company shall give notice to the Holder by registered mail if at any time prior to the expiration or exercise in full of the Warrants,
any of the following events shall occur:

 

(a) a dissolution, liquidation
or winding up of the Company shall be proposed;

 

(b) a capital reorganization
or reclassification of the Common (other than a change in par value, or from par value to no par value, or from no par value to
par value, or as a result of any subdivision, combination, stock dividend or other distribution) or any consolidation or merger
of the Company with or into another corporation (other than a consolidation or merger with another corporation in which the Company
is the acquiring and the surviving corporation and which does not result in any reclassification or change of outstanding securities
issuable upon exercise of this Warrant), or in case of any sale of all or substantially all of the assets of the Company; or

 

(c) a taking by the Company
of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive
any dividend (other than a cash dividend) for other distribution, any right to subscribe for, purchase or otherwise acquire any
shares of stock of any class or any other securities or property, or to receive any other rights.

 

    4

     

    

 

Such giving of notice shall be simultaneous
with (or in any event, no later than) the giving of notice to holders of Common. Such notice shall specify the record date or the
date of closing the stock transfer books, as the case may be. Failure to provide such notice shall not affect the validity of any
action contemplated in this Section 11.

 

12. Restricted
Securities. The Holder understands that this Warrant and the Shares purchasable hereunder constitute “restricted
securities” under the federal securities laws inasmuch as they are, or will be, acquired from the Company in transactions
not involving a public offering and accordingly may not, under such laws and applicable regulations, be resold or transferred without
registration under the Act, or an applicable exemption from such registration. The Holder further acknowledges that an appropriate
legend to the foregoing effect shall be placed on any Shares issued to the Holder upon exercise of this Warrant.

 

13. Disposition
of Shares; Transferability.

 

13.1 Transfer.
The Holder may not, directly or indirectly, sell, exchange, assign or otherwise transfer all or any portion of this Warrant without
the prior written consent of the Company. Upon any transfer, the Company shall execute and deliver a new Warrant to the person
entitled thereto. For purposes of this section, “Affiliate” means any person that, directly or indirectly through one
or more intermediaries, controls or is controlled by or is under common control with a person, as such terms are used in and construed
under Rule 405 under the Securities Act of 1933, as amended.

 

13.2 Rights,
Preferences and Privileges of Common. The powers, preferences, rights, restrictions and other matters relating to the shares
of Common will be as determined in the Company’s Certificate of Incorporation, as amended, as then in effect.

 

14. Miscellaneous.

 

14.1 Binding
Effect. This Warrant and the various rights and obligations arising hereunder shall be binding upon and inure to the benefit
of the parties hereto and their respective successors and assigns.

 

14.2 Entire Agreement.
This Warrant constitutes the entire agreement between the parties with respect to the subject matter hereof and supersede all prior
and contemporaneous agreements, whether oral or written, between the parties hereto with respect to the subject matter hereof.

 

14.3 Amendment
and Waiver. Any term of this Warrant may be amended and the observance of any term hereof may be waived (either generally
or in a particular instance and either retroactively or prospectively), with the written consent of the Company and the Holders.
Any waiver or amendment effected in accordance with this Section 14.3 shall be binding upon the Holder and the Company.

 

    5

     

    

 

14.4 Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable
to contracts made and to be performed wholly within such state. THE COMPANY AND THE HOLDER WAIVE ANY RIGHT TO A JURY TRIAL OF ANY
CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREIN, INCLUDING CLAIMS BASED
ON CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER COMMON LAW OR STATUTORY BASES. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the County of New York, State of New York for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein.

 

14.5 Headings.
The headings in this Agreement are for convenience only and shall not alter or otherwise affect the meaning hereof.

 

14.6 Severability.
If one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision shall be excluded from
this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and the balance shall be
enforceable in accordance with its terms.

 

14.7 Notices.
Unless otherwise provided, any notice required or permitted under this Warrant shall be given in the same manner as provided in
the Agreement.

 

IN WITNESS WHEREOF,
the parties hereto have executed and delivered this Warrant as of the date appearing on the first page of this Warrant.

 

	 	THE COMPANY:
	 	 	 
	 	ONDAS HOLDINGS INC.
	 	 	 
	 	By:	 
	 	Name:	Eric A. Brock
	 	Title:	Chief Executive Officer

 

    6

     

    

 

ANNEX I

 

NOTICE OF EXERCISE

 

		To:	Ondas Holdings Inc.

 

1. The
undersigned Holder hereby elects to purchase _____________ shares of common stock, $0.0001 par value per share (the “Shares”)
of Ondas Holdings Inc., a Nevada corporation (the “Company”), pursuant to the terms of the attached Warrant.

 

The Holder is hereby delivering the sum
of $_______________, in lawful money of the United States, to the Company in accordance with the terms of the Warrant.

 

2. Please
issue and deliver certificates representing the Warrant Shares purchased hereunder to Holder: ________________________, Address:
____________________________ in the following denominations: ____________________________.

 

Taxpayer ID No.: __________________________________

 

If delivery of the Warrant Shares is requested
via DWAC, please check this box and provide the requested information:

 

		☐	The
                                         Company is requested to electronically transmit the Warrant Shares issuable pursuant
                                         to this Notice of Exercise to the account of the Holder with DTC through its Deposit
                                         Withdrawal Agent Commission system (“DWAC Transfer”).

 

Name of DTC Prime Broker:__________________________________________________________________________

 

Account Number: _________________________________________________________________________________

 

3. Please
issue a new Warrant for the unexercised portion of the attached Warrant, if any, in the name of the undersigned.

 

	Holder:	 
	Dated:	 
	By:	 
	Its:	 
	Address:	 

 

4. Investor
Status. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ___________________________________________________________________________

 

Signature of Authorized Signatory of Investing
Entity: _____________________________________________________

 

Name of Authorized Signatory: _______________________________________________________________________

 

Title of Authorized Signatory: ________________________________________________________________________

 

Date: ___________________________________________________________________________________________Exhibit 10.1

 

FORM
OF

SECURITIES PURCHASE AGREEMENT

 

This
SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the [●]  day of [●] 2019, by
and between Ondas Holdings Inc., a Nevada corporation (the “Company”), and each individual or entity named
on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all
of such individuals or entities, collectively, the “Buyers”).

 

RECITALS

 

A.
Subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933,
as amended (the “Securities Act”), and Rule 506(b) promulgated thereunder, the Company desires to issue and
sell to each Buyer, and each Buyer, severally and not jointly, desires to purchase from the Company, securities of the Company
as more fully described in this Agreement.

 

B.
In connection with the offering, the Company, together with National Securities Corporation (the “Placement Agent”),
have entered into an escrow agreement, in the form attached hereto as Exhibit C (the “Escrow Agreement”),
with Signature Bank (the “Escrow Agent”), to hold the Purchase Price (as hereinafter defined), to be released
at the Closing to the Company, upon the written consent of the Company and the Placement Agent.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the premises and the mutual covenants of the parties hereinafter expressed and other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, each intending to be legally bound,
agree as follows:

 

ARTICLE
I 

RECITALS,
EXHIBITS, SCHEDULES

 

The
foregoing recitals are true and correct and, together with the Schedules and Exhibits referred to hereafter, are hereby incorporated
into this Agreement by this reference.

 

ARTICLE
II 

DEFINITIONS

 

For
purposes of this Agreement, except as otherwise expressly provided or otherwise defined elsewhere in this Agreement, or unless
the context otherwise requires, the capitalized terms in this Agreement shall have the meanings assigned to them in this Article
as follows:

 

2.1
“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities
Act.

 

     

     

    

 

2.2
“Assets” means all of the properties and assets of the Company and its Subsidiaries, whether real, personal
or mixed, tangible or intangible, wherever located, whether now owned or hereafter acquired.

 

2.3
“Buyer’s Purchase Price” shall mean, with respect to any Buyer, the “Purchase Price” opposite
such Buyer’s name on the Schedule of Buyers.

 

2.4
“Claims” means any Proceedings, Judgments, Obligations, known threats, losses, damages, deficiencies, settlements,
assessments, charges, costs and expenses of any nature or kind.

 

2.5
“Common Stock” means the Company’s common stock, $0.0001 par value per share.

 

2.6
“Contract” means any written contract, agreement, order or commitment of any nature whatsoever, including,
any sales order, purchase order, lease, sublease, license agreement, services agreement, loan agreement, mortgage, security agreement,
guarantee, management contract, employment agreement, consulting agreement, partnership agreement, shareholders agreement, buy-sell
agreement, option, warrant, debenture, subscription, call or put.

 

2.7
“Encumbrance” means any lien, security interest, pledge, mortgage, easement, leasehold, assessment, tax, covenant,
restriction, reservation, conditional sale, prior assignment, or any other encumbrance, claim, burden or charge of any nature
whatsoever.

 

2.8
“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.

 

2.9
“GAAP” means generally accepted accounting principles, methods and practices set forth in the opinions and
pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants, and statements and
pronouncements of the Financial Accounting Standards Board, the SEC or of such other Person as may be approved by a significant
segment of the U.S. accounting profession, in each case as of the date or period at issue, and as applied in the U.S. to U.S.
companies.

 

2.10
“Governmental Authority” means any foreign, federal, state or local government, or any political subdivision
thereof, or any court, agency or other body, organization, group, stock market or exchange exercising any executive, legislative,
judicial, quasi-judicial, regulatory or administrative function of government.

 

2.11
“Judgment” means any final order, writ, injunction, fine, citation, award, decree, or any other judgment of
any nature whatsoever of any Governmental Authority.

 

2.12
“Law” means any provision of any law, statute, ordinance, code, constitution, charter, treaty, rule or regulation
of any Governmental Authority applicable to the Company.

 

    2

     

    

 

2.13
“Material Adverse Effect” means with respect to the event, item or question at issue, that such event, item
or question would not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or
enforceability of this Agreement or any of the Transaction Documents; (ii) a material adverse effect on the results of operations,
Assets, business or condition (financial or otherwise) of the Company and its subsidiaries, taken as a whole; or (iii) a material
adverse effect on the Company’s or its subsidiaries’ ability to perform, on a timely basis, its or their respective
Obligations under this Agreement or any Transaction Documents.

 

2.14
“Obligation” means any debt, liability or obligation of any nature whatsoever, whether secured, unsecured,
recourse, nonrecourse, liquidated, unliquidated, accrued, absolute, fixed, contingent, ascertained, unascertained, known, unknown
or obligations under executory Contracts.

 

2.15
“Person” means any individual, sole proprietorship, joint venture, partnership, company, corporation, association,
cooperation, trust, estate, Governmental Authority, or any other entity of any nature whatsoever.

 

2.16
“Principal Trading Market” shall mean the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq
Capital Market, the OTC Markets, including the OTCQX, OTCQB and Pink Markets, the NYSE Euronext or the New York Stock Exchange,
whichever is at the time the principal trading exchange or market for the Common Stock.

 

2.17
“Proceeding” means any demand, claim, suit, action, litigation, investigation, audit, study, arbitration, administrative
hearing, or any other proceeding of any nature whatsoever.

 

2.18
“Registration Rights Agreement” means the Registration Rights Agreement, dated the date hereof, among the Company
and the Buyers, in the form of Exhibit A attached hereto.

 

2.19
“SEC” means the United States Securities and Exchange Commission.

 

2.20
“Securities” means collectively, the Units, the Shares, the Warrants and the Warrant Shares, and where applicable
the Placement Agent Warrant.

 

2.21
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

2.22
“Shares” means up to 5,000,000 shares of Common Stock made part of the Units issued or issuable to the Buyers
pursuant to this Agreement.

 

2.23
“Tax” means (i) any foreign, federal, state or local income, profits, gross receipts, franchise, sales, use,
occupancy, general property, real property, personal property, intangible property, transfer, fuel, excise, accumulated earnings,
personal holding company, unemployment compensation, social security, withholding taxes, payroll taxes, or any other tax of any
nature whatsoever, (ii) any foreign, federal, state or local organization fee, qualification fee, annual report fee, filing fee,
occupation fee, assessment, rent, or any other fee or charge of any nature whatsoever, or (iii) any deficiency, interest or penalty
imposed with respect to any of the foregoing.

 

    3

     

    

 

2.24
“Transaction Documents” means this Agreement, the Warrants, the Escrow Agreement, the Placement Agent Warrant
and the Registration Rights Agreement executed in connection with the transactions contemplated hereunder.

 

2.25
“Unit” means one Share and one-half of one Warrant.

 

2.26
“Warrants” means the Warrants, dated the date hereof, issued by the Company to each Buyer, in the form of Exhibit
B attached hereto, which will be exercisable commencing the Closing Date until the third anniversary of the Closing Date,
at an exercise price of $3.25 per share of the Company’s Common Stock.

 

2.27
“Warrant Shares” means the shares of Common Stock underlying the Warrants.

  

ARTICLE
III 

INTERPRETATION

 

In
this Agreement, unless the express context otherwise requires: (i) the words “herein,” “hereof” and “hereunder”
and words of similar import refer to this Agreement as a whole and not to any particular provision of this Agreement; (ii) references
to the words “Article” or “Section” refer to the respective Articles and Sections of this Agreement, and
references to “Exhibit” or “Schedule” refer to the respective Exhibits and Schedules annexed hereto; (iii)
references to a “party” mean a party to this Agreement and include references to such party’s permitted successors
and permitted assigns; (iv) references to a “third party” mean a Person not a party to this Agreement; (v) the terms
“dollars” and “$” means U.S. dollars; (vi) wherever the word “include,” “includes”
or “including” is used in this Agreement, it will be deemed to be followed by the words “without limitation.”

 

ARTICLE
IV 

PURCHASE
AND SALE

 

4.1
Sale and Issuance of Units. Subject to the terms and conditions of this Agreement, each Buyer agrees, severally and not
jointly, to purchase, and the Company agrees to sell and issue to each Buyer, the number of Units set forth in the column designated
“Number of Units” opposite such Buyer’s name on the Schedule of Buyers, which in the aggregate shall be up to
Twelve Million Five Hundred Thousand Dollars ($12,500,000) of Units (including an over-allotment option exercisable by the Placement
Agent for the Company to sell up to an additional $2,500,000 of Units), at a cash purchase price of $2.50 per Unit (the “Purchase
Price”). The Company’s agreement with each Buyer is a separate agreement, and the sale and issuance of the Units
to each Buyer is a separate sale and issuance.

 

4.2
Closing. The purchase, sale and issuance of the Shares and the Warrants (the “Closing”) shall take place
at the offices of Akerman LLP, 350 East Las Olas Boulevard, Fort Lauderdale, Florida 33301, or such other location as the parties
shall mutually agree, no later than the second business day following the satisfaction or waiver of the conditions provided in
Articles VIII and IX of this Agreement (other than conditions that, by their terms, are intended to be satisfied at the Closing,
but subject to the satisfaction or waiver of those conditions) (the “Closing Date”), but in no event later
than the Outside Closing Date.

 

4.3
Form of Payment; Delivery. At the Closing, each Buyer shall deliver to the Company the Buyer’s Purchase Price by
the release of the Buyer’s Purchase Price from escrow in accordance with the Escrow Agreement.

 

    4

     

    

 

ARTICLE
V 

BUYERS’
REPRESENTATIONS AND WARRANTIES

 

Each
Buyer represents and warrants to the Company, that:

 

5.1
Investment Purpose. Each Buyer is acquiring the Securities for its own account for investment only and not with a view
towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered or exempted
under the Securities Act; provided, however, that by making the representations herein, each Buyer reserves the right to dispose
of the Securities at any time in accordance with or pursuant to an effective registration statement covering such Securities or
an available exemption under the Securities Act. The Buyer acknowledges that a legend will be placed on the certificates representing
the Securities in the following form:

 

THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND
ARE “RESTRICTED SECURITIES” AS THAT TERM IS DEFINED IN RULE 144 UNDER THE SECURITIES ACT. SUCH SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT AND THE APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN EXEMPTION FROM REGISTRATION THEREUNDER, THE AVAILABILITY OF WHICH
IS TO BE ESTABLISHED TO THE REASONABLE SATISFACTION OF COUNSEL TO THE ISSUER.

 

5.2
Accredited Investor Status. Each Buyer is an “accredited investor” as that term is defined in Rule 501(a) of
Regulation D, as promulgated under the Securities Act.

 

5.3
Reliance on Exemptions. Each Buyer understands that the Securities are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state securities Laws and that the Company is relying
in part upon the truth and accuracy of, and each Buyer’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of each Buyer set forth herein in order to determine the availability of such exemptions and the eligibility
of each Buyer to acquire the Securities.

 

5.4
Cooling-Off Period. The Buyer acknowledges the following: (1) the offering of the Securities is not registered under the
Securities Act; (2) the Securities will be “restricted securities” (as that term is defined under Rule 144(a)(3) of
the Securities Act and such Securities may not be resold unless they are registered under the Securities Act or an exemption from
registration is available; (3) the Buyers in the offering do not have the protection of Section 11 of the Securities Act; and
(4) a registration statement on Form S-1 (Reg. No. 333-230855) for an abandoned offering was previously filed and withdrawn, effective
August 1, 2019.

 

    5

     

    

 

5.5
Information. Each Buyer and its advisors, if any, have been furnished with all materials relating to the business, finances
and operations of the Company and other information each Buyer deemed material to making an informed investment decision regarding
its purchase of the Shares and Warrants, which have been requested by such Buyer. Each Buyer acknowledges that it has received
and reviewed a copy of the SEC Documents, which are available on the SEC’s website (www.sec.gov)
at no charge to Buyers. Buyers acknowledge that each of them may retrieve all SEC Documents from such website and each Buyer’s
access to such SEC Documents through such website shall constitute delivery of the SEC Documents to Buyers. Each Buyer and its
advisors, if any, have been afforded the opportunity to ask questions of the Company and its management. Each Buyer understands
that its investment in the Securities involves a high degree of risk. Each Buyer is in a position regarding the Company, which,
based upon employment, family relationship or economic bargaining power, enabled and enables such Buyer to obtain information
from the Company in order to evaluate the merits and risks of this investment. Each Buyer has sought such accounting, legal and
tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.
Without limiting the foregoing, each Buyer has carefully considered the potential risks relating to the Company and a purchase
of the Securities, and fully understands that the Securities are a speculative investment that involves a high degree of risk
of loss of the Buyer’s entire investment. Among other things, each Buyer has carefully considered each of the risks described
under the heading “Risk Factors” in the Company’s Form 10-K filed with the SEC on March 19, 2019 (the “Form
10-K”).

 

5.6
Minimum Offering. Each Buyer understands that the minimum purchase by any Buyer shall be $100,000, except that subscriptions
for a lesser amount may be accepted in the discretion, and mutual agreement, of the Company and Placement Agent. Each Buyer further
understands that the Company may accept such Buyer’s purchase hereunder, at any time once the Company shall have received
an aggregate purchase price in the amount of at least $5,000,000. Any officer or director of the Company or the Placement Agent,
or any of such parties affiliates, may participate in this offering and their investment, if any, will count towards the foregoing
minimum amount. As such, Buyer understands that the Company may not receive proceeds hereunder in any amount greater than $12,500,000
(including an over-allotment option exercisable by the Placement Agent for the Company to sell up to an additional $2,500,000
of Units), which may limit the Company’s ability to execute upon its intended business plan.

 

5.7
No Governmental Review. Each Buyer understands that no United States federal or state Governmental Authority has passed
on or made any recommendation or endorsement of the Securities, or the fairness or suitability of the investment in the Securities,
nor have such Governmental Authorities passed upon or endorsed the merits of the offering of the Securities.

 

5.8
Authorization, Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of each
Buyer and is a valid and binding agreement of each Buyer, enforceable in accordance with its terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and
other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

    6

     

    

 

5.9
General Solicitation. No Buyer is purchasing any Securities as a result of any advertisement, article, notice or other
communication published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any
seminar or any other general solicitation or general advertisement. Each Buyer represents that it has a relationship with the
Placement Agent or the Company preceding the offering of the Shares and the Warrants.

 

ARTICLE
VI 

REPRESENTATIONS
AND WARRANTIES OF THE COMPANY

 

Except
as set forth and disclosed in the Company’s disclosure schedules (“Disclosure Schedules”) attached to
this Agreement and made a part hereof or the SEC Documents, the Company and the Subsidiaries each hereby makes the following representations
and warranties to the Buyer. The Disclosure Schedules shall be arranged in sections corresponding to the numbered and lettered
sections and subsections contained in this Article VI and certain other sections of this Agreement, and the disclosures
in any section or subsection of the Disclosure Schedules shall qualify other sections and subsections in this Article VI
only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections
and subsections.

 

6.1
Organization. The Company and each of its subsidiaries (as defined in Rule 405 of the Securities Act) (“Subsidiaries”)
are duly organized, validly existing as a corporation or other business entity and are in good standing under the Laws of their
respective jurisdictions of organization. The Company and each of its Subsidiaries are duly licensed or qualified as a foreign
corporation for transaction of business and in good standing under the Laws of each other jurisdiction in which their respective
ownership or lease of property or the conduct of their respective businesses requires such license or qualification, and have
all corporate power and authority necessary to own or hold their respective properties and to conduct their respective businesses,
except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in
the aggregate, have a Material Adverse Effect or would reasonably be expected to have a Material Adverse Effect. Schedule 6.1
to this Agreement lists all of the Subsidiaries of the Company as of the date of this Agreement and each Subsidiary’s respective
jurisdiction of organization.

 

6.2
Subsidiaries. The Company owns, directly or indirectly, all of the equity interests of the Subsidiaries free and clear
of any lien, charge, security interest, encumbrance, right of first refusal or other restriction, and all the equity interests
of the Subsidiaries are validly issued and are fully paid, nonassessable and free of preemptive and similar rights. No Subsidiary
is currently prohibited, directly or indirectly, from paying any dividends to the Company, from making any other distribution
on such Subsidiary’s capital stock, from repaying to the Company any loans or advances to such Subsidiary from the Company
or from transferring any of such Subsidiary’s property or assets to the Company or any other Subsidiary of the Company.

 

    7

     

    

 

6.3
Capitalization. The issued and outstanding shares of capital stock of the Company have been validly issued, are fully paid
and nonassessable and are not subject to any preemptive rights, rights of first refusal or similar rights. The Company has an
authorized, issued and outstanding capitalization as set forth in Schedule 6.3 to this Agreement and such authorized capital stock
conforms in all material respects to the description thereof set forth in the SEC Documents. The description of the securities
of the Company in the SEC Documents is complete and accurate in all material respects. Except as set forth in Schedule 6.3 to
this Agreement, as of the date referred to therein, the Company does not have outstanding any options to purchase, or any rights
or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or commitments
to issue or sell, any shares of capital stock or other securities.

 

6.4
Authorization; Enforceability. The Company has full legal right, power and authority to enter into this Agreement and perform
the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company and is a
legal, valid and binding agreement of the Company enforceable in accordance with its terms, except to the extent that enforceability
may be limited by bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting creditors’ rights generally
and by general equitable principles.

 

6.5
No Conflicts. Neither the execution of this Agreement, nor the issuance, offering or sale of the Securities, nor the consummation
of any of the transactions contemplated herein and therein, nor the compliance by the Company with the terms and provisions hereof
and thereof will conflict with, or will result in a breach of, any of the terms and provisions of, or has constituted or will
constitute a default under, or has resulted in or will result in the creation or imposition of any lien, charge or encumbrance
upon any property or assets of the Company pursuant to the terms of any contract or other agreement to which the Company may be
bound or to which any of the property or assets of the Company is subject, except (i) such conflicts, breaches or defaults as
may have been waived and (ii) such conflicts, breaches and defaults that would not reasonably be expected to have a Material Adverse
Effect; nor will such action result (x) in any violation of the provisions of the organizational or governing documents of the
Company, or (y) in any violation of the provisions of any statute or any order, rule or regulation applicable to the Company or
of any Governmental Authority having jurisdiction over the Company other than (for the avoidance of doubt, solely with respect
to clause (y)) any violation that would not have a Material Adverse Effect.

 

6.6
Issuance of Securities. The Securities are duly authorized and, upon issuance in accordance with the terms hereof (and
of the Warrants), shall be duly issued, fully paid and non-assessable, and free from all Encumbrances with respect to the issue
thereof, and, assuming the accuracy of the representations and warranties of the Buyers set forth in Article V above, will
be issued in compliance with all applicable United States federal and state securities Laws. Assuming the accuracy of the representations
and warranties of the Buyers set forth in Article V above, the offer and sale by the Company of the Units is exempt from:
(i) the registration and prospectus delivery requirements of the Securities Act; and (ii) the registration and/or qualification
provisions of all applicable state and provincial securities and “blue sky” laws.

 

    8

     

    

 

6.7
No Reliance. The Company has not relied upon the Placement Agent or legal counsel for the Placement Agent for any legal,
tax or accounting advice in connection with the offering and sale of the Securities.

 

6.8
No Consents Required. No consent, approval, authorization, order, registration or qualification of or with any Governmental
Authority is required for the execution, delivery and performance by the Company of this Agreement, the issuance and sale by the
Company of the Securities, except for such consents, approvals, authorizations, orders and registrations or qualifications as
may be required under applicable state securities Laws or Laws of the Financial Industry Regulatory Authority Inc. (“FINRA”)
or in connection with the sale of the Securities.

 

6.9
No Preferential Rights. (i) No person, as such term is defined in Rule 1-02 of Regulation S-X promulgated under the Securities
Act (each, a “Person”), has the right, contractual or otherwise, to cause the Company to issue or sell to such
Person any Common Stock or shares of any other capital stock or other securities of the Company, (ii) no Person has any preemptive
rights, resale rights, rights of first refusal, rights of co-sale, or any other rights (whether pursuant to a “poison pill”
provision or otherwise) to purchase any Common Stock or shares of any other capital stock or other securities of the Company,
(iii) no Person has the right to act as an underwriter or as a financial advisor to the Company in connection with the offer and
sale of the Common Stock, and (iv) except for those rights granted pursuant to the Registration Rights Agreement, no Person has
the right, contractual or otherwise, to require the Company to register under the Securities Act any Common Stock or shares of
any other capital stock or other securities of the Company.

 

6.10
Independent Registered Public Accounting Firm. Rosenberg, Rich, Baker, Berman & Co. (the “Accountant”),
who certified the report on the consolidated financial statements of the Company contained in the Form 10-K, are an independent
registered public accounting firm within the meaning of the Securities Act and the rules of the Public Company Accounting Oversight
Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements
of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) with respect to the Company.

 

6.11
Enforceability of Agreements. All agreements between the Company and third parties expressly referenced in the SEC Documents
are legal, valid and binding obligations of the Company enforceable in accordance with their respective terms, except to the extent
that (i) enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting creditors’
rights generally and by general equitable principles and (ii) the indemnification provisions of certain agreements may be limited
by federal or state securities Laws or public policy considerations in respect thereof.

 

6.12
No Violation or Default. Neither the Company nor any of its Subsidiaries is (i) in violation of its charter or by-laws
or similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would
constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture,
mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its Subsidiaries is a
party or by which the Company or any of its Subsidiaries is bound or to which any of the property or assets of the Company or
any of its Subsidiaries are subject; or (iii) in violation of any Law of any Governmental Authority, except, in the case of each
of clauses (ii) and (iii) above, for any such violation or default that would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.

 

    9

     

    

 

6.13
Compliance with Laws. Each of the Company and its Subsidiaries: (A) is and at all times has been in compliance with all
statutes, rules, or regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution,
marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed
by the Company or its Subsidiaries (“Applicable Laws”), except as could not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect; (B) has not received any written or, to the knowledge of the Company,
verbal notice from any other Governmental Authority alleging or asserting noncompliance with any Applicable Laws or any licenses,
certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable
Laws (“Authorizations”); (C) possesses all material Authorizations and such Authorizations are valid and in
full force and effect and are not in material violation of any term of any such Authorizations; (D) has not received written or,
to the knowledge of the Company, verbal notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration
or other action from any Governmental Authority or third party alleging that any product operation or activity is in violation
of any Applicable Laws or Authorizations and has no knowledge that any such Governmental Authority or third party is considering
any such claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has not received written or, to the knowledge
of the Company, verbal notice that any Governmental Authority has taken, is taking or intends to take action to limit, suspend,
modify or revoke any Authorizations and has no knowledge that any such Governmental Authority is considering such action; (F)
has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions
and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms,
notices, applications, records, claims, submissions and supplements or amendments were complete and correct on the date filed
(or were corrected or supplemented by a subsequent submission); and (G) has not, either voluntarily or involuntarily, initiated,
conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert,
post-sale warning, “dear healthcare provider” letter, or other notice or action relating to the alleged lack of safety
or efficacy of any product or any alleged product defect or violation and, to the Company’s knowledge, no third party has
initiated, conducted or intends to initiate any such notice or action.

 

6.14
No Material Adverse Effect. Subsequent to the SEC Documents, there has not been (i) any Material Adverse Effect or the
occurrence of any development that the Company reasonably expects will result in a Material Adverse Effect, (ii) any transaction
which is material to the Company and the Subsidiaries taken as a whole, (iii) any obligation or liability, direct or contingent
(including any off-balance sheet obligations), incurred by the Company or any Subsidiary, which is material to the Company and
the Subsidiaries taken as a whole, (iv) any material change in the capital stock or outstanding long-term indebtedness of the
Company or any of its Subsidiaries or (v) any dividend or distribution of any kind declared, paid or made on the capital stock
of the Company or any Subsidiary, other than in each case above in the ordinary course of business or as otherwise disclosed in
the SEC Documents.

 

    10

     

    

 

6.15
SEC Documents; Financial Statements. The Common Stock is registered pursuant to Section 12 of the Exchange Act and
the Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by it with the
SEC under the Exchange Act (all of the foregoing filed within the two (2) years preceding the date hereof or amended after the
date hereof and all exhibits included therein and financial statements and schedules thereto and documents incorporated by reference
therein, excluding the Company’s Registration Statement on Form S-1 (Reg. No. 333-230855) for an abandoned offering previously
filed and withdrawn, effective August 1, 2019, being hereinafter referred to as the “SEC Documents”). The Company
is current with its filing obligations under the Exchange Act and all SEC Documents have been filed on a timely basis or the Company
has received a valid extension of such time of filing and has filed any such SEC Document prior to the expiration of any such
extension. The Company represents and warrants that true and complete copies of the SEC Documents are available on the SEC’s
website (www.sec.gov) at no charge to Buyers, and Buyers acknowledge that each of them may retrieve all SEC Documents from such
website and each Buyer’s access to such SEC Documents through such website shall constitute delivery of the SEC Documents
to Buyers; provided, however, that if any Buyer is unable to obtain any of such SEC Documents from such website at no charge,
as result of such website not being available or any other reason beyond any Buyer’s control, then upon request from such
Buyer, the Company shall deliver to such Buyer true and complete copies of such SEC Documents. As of their respective dates, the
SEC Documents complied in all material respects with the requirements of the Exchange Act, and none of the SEC Documents, at the
time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were
made, not misleading. None of the statements made in any such SEC Documents is, or has been, required to be amended or updated
under applicable Law (except as such statements have been amended or updated in subsequent filings prior to the date hereof, which
amendments or updates are also part of the SEC Documents). As of their respective dates, the financial statements of the Company
included in the SEC Documents (“Financial Statements”) complied in all material respects with applicable accounting
requirements and the published rules and regulations of the SEC with respect thereto (except as such Financial Statements have
been amended or updated in subsequent filings prior to the date hereof, which amendments or updates are also part of the SEC Documents).
All of the Financial Statements have been prepared in accordance with GAAP, consistently applied, during the periods involved
(except: (i) as may be otherwise indicated in such Financial Statements or the notes thereto; or (ii) in the case of unaudited
interim statements, to the extent they may exclude footnotes or may be condensed or summary statements), and fairly present in
all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results
of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end
audit adjustments). To the knowledge of the Company and its officers, no other information provided by or on behalf of the Company
to the Buyers which is not included in the SEC Documents contains any untrue statement of a material fact or omits to state any
material fact necessary in order to make the statements therein, in the light of the circumstance under which they are or were
made, not misleading.

 

    11

     

    

 

6.16
No Litigation. There are no actions, suits or proceedings by or before any Governmental Authority pending, nor, to the
Company’s knowledge, any audits or investigations by or before any Governmental Authority, to which the Company or a Subsidiary
is a party or to which any property of the Company or any of its Subsidiaries is the subject that, individually or in the aggregate,
if determined adversely to the Company or its Subsidiaries, would reasonably be expected to have a Material Adverse Effect and,
to the Company’s knowledge, no such actions, suits, proceedings, audits or investigations are threatened by any Governmental
Authority or threatened by others; and (i) there are no current or pending audits, investigations, actions, suits or proceedings
by or before any Governmental Authority that are required under the Securities Act to be described in the Disclosure Schedules
that are not so described; and (ii) there are no contracts or other documents that are required under the Securities Act to be
filed as exhibits to the SEC Documents that are not so filed.

 

6.17
Consents and Permits. The Company and its Subsidiaries have made all filings, applications and submissions required by,
possesses and is operating in compliance with, all approvals, licenses, certificates, certifications, clearances, consents, grants,
exemptions, marks, notifications, orders, permits and other authorizations issued by, the appropriate federal, state or foreign
Governmental Authority necessary for the ownership or lease of their respective properties or to conduct its businesses as described
in the SEC Documents (collectively, “Permits”), except for such Permits the failure of which to possess, obtain
or make the same would not reasonably be expected to have a Material Adverse Effect; the Company and its Subsidiaries are in compliance
with the terms and conditions of all such Permits, except where the failure to be in compliance would not reasonably be expected
to have a Material Adverse Effect; all of the Permits are valid and in full force and effect, except where any invalidity, individually
or in the aggregate, would not be reasonably expected to have a Material Adverse Effect; and neither the Company nor any of its
Subsidiaries has received any written notice relating to the limitation, revocation, cancellation, suspension, modification or
non-renewal of any such Permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding,
would reasonably be expected to have a Material Adverse Effect, or has any reason to believe that any such license, certificate,
permit or authorization will not be renewed in the ordinary course. The Company and each Subsidiary possess such valid and current
certificates, authorizations or permits issued by the appropriate state, federal or foreign regulatory agencies or bodies necessary
to conduct their respective businesses, and neither the Company nor any Subsidiary has received, or has any reason to believe
that it will receive, any notice of proceedings relating to the revocation or modification of, or non-compliance with, any such
certificate, authorization or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding,
could reasonably be expected to result in a Material Adverse Effect.

 

6.18
Regulatory Filings. Neither the Company nor any of its Subsidiaries has failed to file with the applicable Governmental
Authority any required filing, declaration, listing, registration, report or submission, except for such failures that, individually
or in the aggregate, would not reasonably be expected to have a Material Adverse Effect; all such filings, declarations, listings,
registrations, reports or submissions were in compliance with applicable Laws when filed and no deficiencies have been asserted
by any applicable regulatory authority with respect to any such filings, declarations, listings, registrations, reports or submissions,
except for any deficiencies that, individually or in the aggregate, would not have a Material Adverse Effect.

 

    12

     

    

 

6.19
Intellectual Property. The Company and its Subsidiaries own, possess, license or have other rights to use all foreign and
domestic patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights,
licenses, inventions, trade secrets, technology, Internet domain names, know-how and other intellectual property (collectively,
the “Intellectual Property”), necessary for the conduct of their respective businesses as now conducted except
to the extent that the failure to own, possess, license or otherwise hold adequate rights to use such Intellectual Property would
not, individually or in the aggregate, have a Material Adverse Effect. (i) There are no rights of third parties to any such Intellectual
Property owned by the Company and its Subsidiaries; (ii) to the Company’s knowledge, there is no infringement by third parties
of any such Intellectual Property; (iii) there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding
or claim by others challenging the Company’s and its Subsidiaries’ rights in or to any such Intellectual Property,
and the Company is unaware of any facts which could form a reasonable basis for any such action, suit, proceeding or claim; (iv)
there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others challenging the
validity or scope of any such Intellectual Property; (v) there is no pending or, to the Company’s knowledge, threatened
action, suit, proceeding or claim by others that the Company and its Subsidiaries infringe or otherwise violate any patent, trademark,
copyright, trade secret or other proprietary rights of others; (vi) to the Company’s knowledge, there is no third-party
U.S. patent or published U.S. patent application which contains claims for which an Interference Proceeding (as defined in 35
U.S.C. § 135) has been commenced against any patent or patent application described in the SEC Documents as being owned by
or licensed to the Company; and (vii) the Company and its Subsidiaries have complied with the terms of each agreement pursuant
to which Intellectual Property has been licensed to the Company or such Subsidiary, and all such agreements are in full force
and effect, except, in the case of any of clauses (i)-(vii) above, for any such infringement by third parties or any such pending
or threatened suit, action, proceeding or claim as would not, individually or in the aggregate, reasonably be expected to result
in a Material Adverse Effect.

 

6.20
No Material Defaults. Neither the Company nor any of the Subsidiaries has defaulted on any installment on indebtedness
for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would reasonably
be expected to have a Material Adverse Effect. The Company has not filed a report pursuant to Section 13(a) or 15(d) of the Exchange
Act since the filing of its last Annual Report indicating that it (i) has failed to pay any dividend or sinking fund installment
on preferred stock or (ii) has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more
long-term leases, which defaults, individually or in the aggregate, would have a Material Adverse Effect. “Annual Report”
means the Annual Report on Form 10-K for the fiscal year of the Company ended December 31, 2018 filed by the Company with the
SEC.

 

    13

     

    

 

6.21
Certain Market Activities. Neither the Company nor any of its subsidiaries has taken, directly or indirectly, any action
designed to or that might reasonably be expected to cause or result in stabilization or manipulation of the price of the Securities
or of any “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation
M”)) with respect to the Securities, whether to facilitate the sale or resale of the Securities or otherwise, and has
taken no action which would directly or indirectly violate Regulation M.

 

6.22
Broker/Dealer Relationships. Neither the Company nor any of the Subsidiaries (i) is required to register as a “broker”
or “dealer” in accordance with the provisions of the Exchange Act or (ii) directly or indirectly through one or more
intermediaries, controls or is a “person associated with a member” or “associated person of a member”
(within the meaning set forth in the FINRA Manual).

 

6.23
Taxes. The Company and each of its Subsidiaries have filed all federal, state, local and foreign tax returns which have
been required to be filed and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become
due and are not being contested in good faith, except where the failure to so file or pay would not have a Material Adverse Effect.
No tax deficiency has been determined adversely to the Company or any of its Subsidiaries which has had, or would have, individually
or in the aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state, provincial or other governmental
tax deficiency, penalty or assessment which has been or might be asserted or threatened against it which would have a Material
Adverse Effect.

 

6.24
Title to Real and Personal Property. The Company and its Subsidiaries have good and marketable title in fee simple to all
items of real property owned by them, good and valid title to all personal property described in the SEC Documents as being owned
by them that are material to the businesses of the Company or such Subsidiary, in each case free and clear of all liens, encumbrances
and claims, except those matters that (i) do not materially interfere with the use made and proposed to be made of such property
by the Company and any of its Subsidiaries or (ii) would not reasonably be expected to, individually or in the aggregate, have
a Material Adverse Effect. Any real or personal property described in the SEC Documents as being leased by the Company and any
of its Subsidiaries is held by them under valid, existing and enforceable leases, except those that (A) do not materially interfere
with the use made or proposed to be made of such property by the Company or any of its Subsidiaries or (B) would not be reasonably
expected, individually or in the aggregate, to have a Material Adverse Effect. Each of the properties of the Company and its Subsidiaries
complies with all applicable Laws (including building and zoning Laws and Laws relating to access to such properties), except
if and to the extent disclosed in the SEC Documents or except for such failures to comply that would not, individually or in the
aggregate, reasonably be expected to interfere in any material respect with the use made and proposed to be made of such property
by the Company and its Subsidiaries or otherwise have a Material Adverse Effect. None of the Company or its Subsidiaries has received
from any Governmental Authorities any notice of any condemnation of, or zoning change affecting, the properties of the Company
and its Subsidiaries, and the Company knows of no such condemnation or zoning change which is threatened, except for such that
would not reasonably be expected to interfere in any material respect with the use made and proposed to be made of such property
by the Company and its Subsidiaries or otherwise have a Material Adverse Effect, individually or in the aggregate.

 

    14

     

    

 

6.25
Environmental Laws. The Company and its Subsidiaries (i) are in compliance with any and all applicable federal, state,
provincial, local and foreign Laws relating to the protection of human health and safety, the environment or hazardous or toxic
substances or wastes, pollutants or contaminants (collectively, “Environmental Laws”); (ii) have received and
are in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct
their respective businesses as described in the SEC Documents; and (iii) have not received notice of any actual or potential liability
for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants,
except, in the case of any of clauses (i), (ii) or (iii) above, for any such failure to comply or failure to receive required
permits, licenses, other approvals or liability as would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.

 

6.26
Periodic Review of Costs of Environmental Compliance. In the ordinary course of its business, the Company conducts a periodic
review of the effect of Environmental Laws on the business, operations and properties of the Company and its Subsidiaries, in
the course of which it identifies and evaluates associated costs and liabilities (including any capital or operating expenditures
required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related
constraints on operating activities and any potential liabilities to third parties). No facts or circumstances have come to the
Company’s attention that could result in costs or liabilities that could be expected, individually or in the aggregate,
to have a Material Adverse Effect.

 

6.27
Disclosure Controls. The Company and each of its Subsidiaries maintain systems of internal accounting controls designed
to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations;
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted
accounting principles and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s
general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company’s internal control over financial
reporting is effective and the Company is not aware of any material weaknesses in its internal control over financial reporting
(other than as set forth in the SEC Documents). Since the date of the latest audited financial statements of the Company included
in the SEC Documents, there has been no change in the Company’s internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting (other than
as set forth in the SEC Documents). The Company has established disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15 and 15d-15) for the Company and designed such disclosure controls and procedures to ensure that material information
relating to the Company and each of its Subsidiaries is made known to the certifying officers by others within those entities.
The Company’s certifying officers have evaluated the effectiveness of the Company’s disclosure controls and procedures
as of a date within 90 days prior to the filing date of the Form 10-K (such date, the “Evaluation Date”). Except
as disclosed in the Form 10-K, the conclusions of the certifying officers about the effectiveness of the disclosure controls and
procedures based on their evaluations as of the Evaluation Date and the disclosure controls and procedures are effective. Since
the Evaluation Date, there have been no significant changes in the Company’s internal controls (as such term is defined
in Item 307(b) of Regulation S-K under the Securities Act) or, to the Company’s knowledge, in other factors that could significantly
affect the Company’s internal controls.

 

    15

     

    

 

6.28
Sarbanes-Oxley. There is and has been no failure on the part of the Company, any Subsidiary of the Company or any of the
Company’s or its Subsidiaries’ respective directors or officers, in their capacities as such, to comply in all material
respects with any applicable provisions of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder. Each of
the principal executive officer and the principal financial officer of the Company (or each former principal executive officer
of the Company and each former principal financial officer of the Company as applicable) has made all certifications required
by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents
required to be filed by it or furnished by it to the SEC. Each of the principal executive officer and the principal financial
officer of each of the Company’s Subsidiaries (or each former principal executive officer of such Subsidiaries and each
former principal financial officer of such Subsidiary as applicable) has made all certifications required by Sections 302 and
906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents required to be filed
by it or furnished by it to the SEC. For purposes of the preceding sentence, “principal executive officer” and “principal
financial officer” shall have the meanings given to such terms in the Sarbanes-Oxley Act.

 

6.29
Labor Disputes. No labor disturbance by or dispute with employees of the Company or any of its Subsidiaries exists or,
to the knowledge of the Company, is threatened which would reasonably be expected to result in a Material Adverse Effect.

 

6.30
Investment Company Act. Neither the Company nor any of the Subsidiaries is, or will be, either after receipt of payment
for the Securities or after the application of the proceeds therefrom as described under “Use of Proceeds” in this
Agreement, required to register as an “investment company” or an entity “controlled” by an “investment
company,” as such terms are defined in the Investment Company Act of 1940.

 

6.31
Operations. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970,
the money laundering Laws of all jurisdictions to which the Company or its Subsidiaries are subject, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority
(collectively, the “Money Laundering Laws”); and no action, suit or proceeding by or before any Governmental
Authority involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company, threatened.

 

6.32
Off-Balance Sheet Arrangements. There are no transactions, arrangements and other relationships between and/or among the
Company, and/or, to the knowledge of the Company, any of its affiliates and any unconsolidated entity, including any structural
finance, special purpose or limited purpose entity (each, an “Off-Balance Sheet Transaction”) that would reasonably
be expected to affect materially the Company’s liquidity or the availability of or requirements for its capital resources,
including those Off-Balance Sheet Transactions described in the SEC’s Statement about Management’s Discussion and
Analysis of Financial Conditions and Results of Operations (Release Nos. 33-8056; 34-45321; FR-61), required to be described in
the SEC Documents which have not been described as required.

 

    16

     

    

 

6.33
ERISA. To the knowledge of the Company, each material employee benefit plan, within the meaning of Section 3(3) of the
Employee Retirement Income Security Act of 1974 (“ERISA”), that is maintained, administered or contributed
to by the Company or any of its affiliates for employees or former employees of the Company and any of its Subsidiaries has been
maintained in material compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations,
including ERISA and the Internal Revenue Code of 1986 (the “Code”); no prohibited transaction, within the meaning
of Section 406 of ERISA or Section 4975 of the Code, has occurred which would result in a material liability to the Company with
respect to any such plan excluding transactions effected pursuant to a statutory or administrative exemption; and for each such
plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no “accumulated funding deficiency”
as defined in Section 412 of the Code has been incurred, whether or not waived, and the fair market value of the assets of each
such plan (excluding for these purposes accrued but unpaid contributions) exceeds the present value of all benefits accrued under
such plan determined using reasonable actuarial assumptions.

 

6.34
Forward-Looking Statements. Each financial or operational projection or other “forward-looking statement” (as
defined by Section 27A of the Securities Act or Section 21E of the Exchange Act) contained in the SEC Documents (i) was so included
by the Company in good faith and with reasonable basis after due consideration by the Company of the underlying assumptions, estimates
and other applicable facts and circumstances and (ii) is accompanied by meaningful cautionary statements identifying those factors
that could cause actual results to differ materially from those in such forward-looking statement. No such statement was made
with the knowledge of an executive officer or director of the Company that such statement was false or misleading.

 

6.35
Rules. Neither the issuance, sale and delivery of the Securities nor the application of the proceeds thereof by the Company
as described in this Agreement will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any
other regulation of such Board of Governors.

 

6.36
Insurance. The Company and each of its Subsidiaries carry, or are covered by, insurance in such amounts and covering such
risks as the Company and each of its Subsidiaries reasonably believe are adequate for the conduct of their properties and as is
customary for companies engaged in similar businesses in similar industries.

 

    17

     

    

 

6.37
No Improper Practices. (i) Neither the Company nor the Subsidiaries, nor any director, officer, or employee of the Company
or any Subsidiary or, to the Company’s knowledge, any agent, affiliate or other person acting on behalf of the Company or
any Subsidiary has, in the past five years, made any unlawful contributions to any candidate for any political office (or failed
fully to disclose any contribution in violation of applicable Law) or made any contribution or other payment to any official of,
or candidate for, any federal, state, municipal, or foreign office or other person charged with similar public or quasi-public
duty in violation of any applicable Law or of the character required to be disclosed in the SEC Documents; (ii) no relationship,
direct or indirect, exists between or among the Company or any Subsidiary or, to the Company’s knowledge, any affiliate
of any of them, on the one hand, and the directors, officers and stockholders of the Company or any Subsidiary, on the other hand,
that is required by the Securities Act to be described in the SEC Documents that is not so described; (iii) no relationship, direct
or indirect, exists between or among the Company or any Subsidiary or any affiliate of them, on the one hand, and the directors,
officers, or stockholders of the Company or any Subsidiary, on the other hand, that is required by the rules of FINRA to be described
in the SEC Documents that is not so described; (iv) except as described in the SEC Documents, there are no material outstanding
loans or advances or material guarantees of indebtedness by the Company or any Subsidiary to or for the benefit of any of their
respective officers or directors or any of the members of the families of any of them; and (v) the Company has not offered, or
caused any placement agent to offer, Common Stock to any person with the intent to influence unlawfully (A) a customer or supplier
of the Company or any Subsidiary to alter the customer’s or supplier’s level or type of business with the Company
or any Subsidiary or (B) a trade journalist or publication to write or publish favorable information about the Company or any
Subsidiary or any of their respective products or services, and, (vi) neither the Company nor any Subsidiary nor any director,
officer, employee, or, to the Company’s knowledge, agent, affiliate or other person acting on behalf of the Company, or
any Subsidiary has (A) violated or is in violation of any applicable provision of the U.S. Foreign Corrupt Practices Act of 1977,
or any other applicable anti-bribery or anti-corruption Law (collectively, “Anti-Corruption Laws”), (B) promised,
offered, provided, attempted to provide or authorized the provision of anything of value, directly or indirectly, to any person
for the purpose of obtaining or retaining business, influencing any act or decision of the recipient or securing any improper
advantage, or (C) made any payment of funds of the Company or any Subsidiary or received or retained any funds in violation of
any Anti-Corruption Laws.

 

6.38
Sanctions.

 

(i)
The Company represents that, neither the Company nor any of its Subsidiaries (collectively, the “Entity”) or
any director, officer, employee, agent, affiliate or representative of the Entity, is a government, individual, or entity (in
this paragraph, “Person”) that is, or is owned or controlled by a Person that is:

 

(A)
the subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office of Foreign Assets Control
(“OFAC”), the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant
sanctions authorities, including designation on OFAC’s Specially Designated Nationals and Blocked Persons List or OFAC’s
Foreign Sanctions Evaders List (as amended, collectively, “Sanctions”), nor

 

(B)
located, organized or resident in a country or territory that is the subject of Sanctions that broadly prohibit dealings with
that country or territory (including Cuba, Iran, North Korea, Sudan, Syria and the Crimea Region of the Ukraine) (the “Sanctioned
Countries”).

 

(ii)
The Entity represents and covenants that it will not, directly or indirectly, use the proceeds of the offering, or lend, contribute
or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person:

 

(A)
to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such
funding or facilitation, is the subject of Sanctions or is a Sanctioned Country; or

 

(B)
in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering,
whether as underwriter, advisor, investor or otherwise).

 

    18

     

    

 

(iii)
The Entity represents and covenants that, except as detailed in the SEC Documents, for the past 5 years, it has not knowingly
engaged in, is not now knowingly engaging in, and will not engage in, any dealings or transactions with any Person, or in any
country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions or is or was a Sanctioned
Country.

 

6.39
Related-Party Transactions. There are no business relationships or related-party transactions involving the Company or
any of its subsidiaries or any other person required to be described in the SEC Documents that have not been described as required.

 

6.40
FINRA Matters. All of the information provided to the Placement Agent or to counsel for the Placement Agent by the Company,
and, to the knowledge of the Company, its counsel, its officers and directors and the holders of any securities (debt or equity)
or options to acquire any securities of the Company in connection with the offering of the Securities is true, complete, correct
and compliant with FINRA’s rules and any letters, filings or other supplemental information provided to FINRA pursuant to
FINRA Rules is true, complete and correct.

 

6.41
Parties to Lock-Up Agreements. The Company has furnished to the Placement Agent a letter agreement in the form attached
hereto as Exhibit D (the “Lock-up Agreement”) from each of the persons listed on Exhibit E. Such
Exhibit E lists under an appropriate caption the directors and executive officers of the Company.

 

6.42
Dividend Restrictions. No subsidiary of the Company is prohibited or restricted, directly or indirectly, from paying dividends
to the Company, or from making any other distribution with respect to such subsidiary’s equity securities or from repaying
to the Company or any other subsidiary of the Company any amounts that may from time to time become due under any loans or advances
to such subsidiary from the Company or from transferring any property or assets to the Company or to any other subsidiary.

 

    19

     

    

 

6.43
2018 Merger. The Company was party to a merger by and among the Company (formerly known as Zev Ventures Incorporated),
Ondas Networks Inc. (the “OpCo”) and Zev Merger Sub, Inc. pursuant to an Agreement and Plan of Merger and Reorganization
dated September 18, 2018 (the “Merger Agreement”) and is, as a result of the transactions contemplated by the
Merger Agreement, the sole owner of OpCo. The Merger Agreement is publicly available as Exhibit 2.1 to the Company’s Form
8-K dated September 28, 2018. The Merger Agreement is a valid and legally binding obligation of the Company and each other party
thereto, enforceable against it and such other parties in accordance with its terms, except: (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law. There has been no material breach of any of the terms and conditions of the Merger Agreement by the Company or any of the
other parties thereto as of the Effective Date.

 

6.44
Acknowledgment Regarding Buyers’ Purchase of the Units. The Company acknowledges and agrees that each Buyer is acting
solely in the capacity of an arm’s length purchaser with respect to this Agreement and the transactions contemplated hereby.
The Company further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to this Agreement and the transactions contemplated hereby and any advice given by any Buyer or any of
its representatives or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental
to such Buyer’s purchase of the Units. The Company further represents to each Buyer that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation by the Company and its representatives.

 

6.45
Listing and Maintenance Requirements. The Company’s Common Stock is registered pursuant to Section 12 of the Exchange
Act, and the Company has taken no action designed to, or which to the best of its knowledge is likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act, nor has the Company received any notification that the SEC is contemplating
terminating such registration.

 

6.46
Bad Actor. No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a
“Disqualification Event”) is applicable to the Company or, to the Company’s knowledge, any Company Covered
Person, except for a Disqualification Event as to which Rule 506(d)(2)(ii—iv) or (d)(3), is applicable. As used in this
Section 6.46, the term “Company Covered Person” means, with respect to the Company as an “issuer”
for purposes of Rule 506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1).

 

6.47
Brokers. Neither the Company nor any of the Subsidiaries has incurred any liability for any finder’s fees, brokerage
commissions or similar payments in connection with the transactions herein contemplated, except with respect to or pursuant to
this Agreement and as set forth on Schedule 6.47 to this Agreement.

 

    20

     

    

 

ARTICLE
VII 

COVENANTS

 

7.1
Best Efforts. Each party shall use its best efforts to timely satisfy each of the conditions to be satisfied by it as provided
in Articles VIII and IX of this Agreement.

 

7.2
Form D. If required by applicable Law, the Company agrees to file a Form D with respect to the Shares and the Warrants
as required under Regulation D of the Securities Act and to provide a copy thereof to the Placement Agent. The Company shall,
on or before the Closing Date, take such action as the Company shall reasonably determine is necessary to qualify the Shares and
the Warrants, or obtain an exemption for the Shares and the Warrants for sale to each of the Buyers at Closing pursuant to this
Agreement under applicable securities or “Blue Sky” Laws of the states of the United States, and shall provide evidence
of any such action so taken to the Placement Agent on or prior to the Closing Date.

 

7.3
Affirmative Covenants.

 

(a)
Reporting Status; Listing. Until the earlier of three (3) years from the date hereof or when the Shares, Warrants and Warrant
Shares are no longer registered in the names of the Buyers on the books and records of the Company, the Company shall: (i) file
in a timely manner all reports required to be filed under the Securities Act, the Exchange Act or any securities Laws and regulations
thereof applicable to the Company of any state of the United States, or by the rules and regulations of the Principal Trading
Market, and, if not otherwise publicly available, to provide a copy thereof to a Buyer upon request; (ii) not terminate its
status as an issuer required to file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder
would otherwise permit such termination unless in connection with a Sale Event (as defined below); (iii) if required by the rules
and regulations of the Principal Trading Market, promptly secure the listing of any of the Shares or Warrant Shares upon the Principal
Trading Market (subject to official notice of issuance) and, take all reasonable action under its control to maintain the continued
listing, quotation and trading of its Common Stock on the Principal Trading Market, and the Company shall comply in all respects
with the Company’s reporting, filing and other Obligations under the bylaws or rules of the Principal Trading Market, the
Financial Industry Regulatory Authority, Inc. and such other Governmental Authorities, as applicable.

 

(b)
Rule 144. With a view to making available to each Buyer the benefits of Rule 144 under the Securities Act (“Rule
144”), or any similar rule or regulation of the SEC that may at any time permit Buyers to sell any of the Shares or
Warrant Shares to the public without registration, the Company represents and warrants that: (i) the Company is, and has been
for a period of at least ninety (90) days immediately preceding the date hereof, subject to the reporting requirements of Section
13 or 15(d) of the Exchange Act; (ii) the Company has filed all required reports under Section 13 or 15(d) of the Exchange Act,
as applicable, during the twelve (12) months preceding the Closing Date (or for such shorter period that the Company was required
to file such reports); (iii) the Company is not an issuer defined as a “Shell Company” (as hereinafter defined); and
(iv) if the Company has, at any time, been an issuer defined as a Shell Company, the Company has: (A) not been an issuer defined
as a Shell Company for at least six (6) months prior to the Closing Date; and (B) has satisfied the requirements of Rule 144(i)
(including, without limitation, the proper filing of “Form 10 information” at least six (6) months prior to the Closing
Date). For the purposes hereof, the term “Shell Company” shall mean an issuer that meets the description set
forth under Rule 144(i)(1)(i). In addition, until the earliest of (x) three (3) years from the date hereof, (y) when the Shares
and Warrant Shares no longer bear a restrictive legend, the Company shall, at its sole expense or (z) sale of all or substantially
all the assets of the Company; any merger, consolidation or acquisition involving the Company with, by or into another corporation,
entity or person; or any change in the ownership of more than fifty percent (50%) of the voting capital stock of the Company in
one or more related transactions (such transactions described in this clause (z), a “Sale Event”),

 

(i)
make, keep and ensure that adequate current public information with respect to the Company, as required in accordance with Rule
144, is publicly available.

 

    21

     

    

 

(ii)
furnish to each Buyer, promptly upon reasonable request: (A) a written statement by the Company that it has complied with the
reporting requirements of Rule 144, the Securities Act and the Exchange Act; and (B) such other information as may be reasonably
requested by each Buyer to permit each Buyer to sell any of the Shares or Warrant pursuant to Rule 144 without limitation or restriction;
and

 

(iii)
promptly at the request of each Buyer, upon the Buyer’s providing customary supporting documentation, give the Company’s
transfer agent instructions to the effect that, upon the transfer agent’s receipt from any Buyer of a certificate (a “Rule
144 Certificate”) certifying that such Buyer’s holding period (as determined in accordance with the provisions of
Rule 144) for any portion of the Shares or Warrant Shares which such Buyer proposes to sell (the “Securities Being Sold”)
is not less than six (6) months and such sale otherwise complies with the requirements of Rule 144, and receipt by the transfer
agent of the “Rule 144 Opinion” (as hereinafter defined) from the Company or its counsel (or from such Buyer and its
counsel as permitted below), the transfer agent is to effect the transfer of the Securities Being Sold and issue to such Buyer
or transferee(s) thereof one or more stock certificates representing the transferred Securities Being Sold without any restrictive
legend and without recording any restrictions on the transferability of such Securities Being Sold on the transfer agent’s
books and records or, at the Buyer’s option, the Securities Being Sold shall be transmitted by the transfer agent to the
Buyer by crediting the account of the Buyer’s or its designee’s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system if the transfer agent is then a participant in such system. In this regard,
upon each Buyer’s request, the Company shall have an affirmative obligation at its expense to cause its counsel to promptly
issue to the transfer agent a legal opinion providing that, based on the Rule 144 Certificate, the Securities Being Sold were
or may be sold, as applicable, pursuant to the provisions of Rule 144, even in the absence of an effective registration statement
(the “Rule 144 Opinion”). If the transfer agent requires any additional documentation in connection with any proposed
transfer by any Buyer of any Securities Being Sold, the Company shall promptly deliver or cause to be delivered to the transfer
agent or to any other Person, all such additional documentation as may be necessary to effectuate the transfer of the Securities
Being Sold and the issuance of an unlegended certificate to any transferee thereof, all at the Company’s expense.

 

    22

     

    

 

7.4
Use of Proceeds. The Company shall use the net proceeds from the sale of the Securities for working capital and general
corporate purposes and payment of the fees and expenses of this offering.

 

7.5
Fees and Expenses. The Company agrees to pay to each Buyer (or any designee or agent of the Buyers), upon demand, or to
otherwise be responsible for the payment of, any and all costs, fees, charges and expenses, including the reasonable fees, costs,
expenses and disbursements of counsel for any Buyer, and of any experts and agents, which any Buyer may incur or which may otherwise
be due and payable in connection with: (i) any documentary stamp taxes, intangibles taxes, recording fees, filing fees, or
other similar taxes, fees or charges imposed by or due to any Governmental Authority in connection with this Agreement or any
other Transaction Documents; (ii) the exercise or enforcement of any of the rights of any Buyer under this Agreement or the
Transaction Documents; or (iii) the failure by the Company to perform or observe any of the provisions of this Agreement
or any of the Transaction Documents. The provisions of this Subsection shall survive the termination of this Agreement.

 

7.6
Public Disclosure of Buyers. The Company shall not publicly disclose the name of any Buyer, or include the name of any
Buyer in any filing with the SEC or any regulatory agency or Principal Trading Market, without the prior written consent of such
Buyer except: (a) as required by federal securities law in connection with any registration statement contemplated by the Registration
Rights Agreement or (b) to the extent such disclosure is required by Law or Principal Trading Market regulations, in which case
the Company shall provide Buyers with prior written notice of such disclosure permitted under this clause (b).

 

 

ARTICLE
VIII 

CONDITIONS
PRECEDENT TO THE COMPANY’S OBLIGATIONS TO SELL

 

The
obligation of the Company hereunder to issue and sell the Securities to a Buyer at the Closing is subject to the satisfaction,
at or before the Closing Date, of each of the following conditions, provided that these conditions are for the Company’s
sole benefit and may be waived by the Company at any time in its sole discretion:

 

8.1
The Buyer shall have executed the Transaction Documents that require the Buyer’s execution, and delivered them to the Company.

 

8.2
The Buyer shall have paid the Buyer’s Purchase Price to the Company, which payment may be made by the release of the Buyer’s
Purchase Price from escrow in accordance with the Escrow Agreement.

 

8.3
The Buyer’s representations and warranties shall be true and correct in all material respects as of the date when made and
as of the applicable Closing Date as though made at that time (except for representations and warranties that speak as of a specific
date), and the Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and
conditions required by this Agreement to be performed, satisfied or complied with by the Buyer at or prior to the applicable Closing
Date.

 

    23

     

    

 

8.4
The Company shall have obtained all governmental, regulatory or third party consents and approvals necessary for the sale of the
Securities.

 

8.5
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.

 

8.6
Since the date of execution of this Agreement, no event or series of events shall have occurred that resulted, or could reasonably
be expected to result, in a Material Adverse Effect.

 

8.7
Trading in the Common Stock shall not have been suspended by the SEC or any Principal Trading Market (except for any suspensions
of trading of not more than one trading day solely to permit dissemination of material information regarding the Company) at any
time since the date of execution of this Agreement.

 

8.8
The Company shall have received an aggregate Purchase Price in the amount of not less than $5,000,000 and no more than $12,500,000
(including an over-allotment option exercisable by the Placement Agent for the Company to sell up to an additional $2,500,000
of Units). Any officer or director of the Company or the Placement Agent, or any of such parties affiliates, may participate in
this offering and their investment, if any, will count towards the foregoing amount.

 

ARTICLE
IX 

CONDITIONS
PRECEDENT TO A BUYER’S OBLIGATIONS TO PURCHASE

 

The
obligation of a Buyer hereunder to purchase the Securities at the Closing is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions (in addition to any other conditions precedent elsewhere in this Agreement), provided
that these conditions are for the Buyer’s sole benefit and may be waived by the Buyer at any time in its sole discretion:

 

9.1
The Company shall have executed and delivered the Transaction Documents and delivered the same to the Placement Agent.

 

9.2
The representations and warranties of the Company and each of the Subsidiaries shall be true and correct in all material respects
(except to the extent that any of such representations and warranties are already qualified as to materiality in Article VI above,
in which case, such representations and warranties shall be true and correct in all respects without further qualification) as
of the date when made and as of the Closing Date as though made at that time (except for representations and warranties that speak
as of a specific date) and the Company and each of the Subsidiaries shall have performed, satisfied and complied in all material
respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with
by the Company and the Subsidiaries at or prior to the Closing Date. The Placement Agent shall have received a certificate, executed
by the Chief Executive Officer or Chief Financial Officer of the Company, dated as of the Closing Date, to the foregoing effect.

 

    24

     

    

 

9.3
The Company shall have delivered to the Placement Agent a certificate evidencing the formation and good standing of the Company
in its jurisdiction of formation issued by the Secretary of State (or comparable office) of such jurisdiction of formation as
of a date within ten (10) days of the Closing Date.

 

9.4
The Company shall have delivered to the Placement Agent a certificate or other reasonably acceptable evidence evidencing the Company’s
qualification as a foreign corporation and good standing issued by the Secretary of State (or comparable office) of each jurisdiction
in which the Company conducts business and is required to so qualify, as of a date within twenty (20) days of the Closing Date.

 

9.5
The Company shall have delivered to the Placement Agent a certificate, in the form acceptable to the Placement Agent, executed
by the Secretary of the Company dated as of the Closing Date, as to (i) the resolutions consistent with Section 6.3 as
adopted by the Company’s board of directors, (ii) the Certificate of Incorporation of the Company and (iii) the Bylaws of
the Company as in effect at the Closing.

 

9.6
No event shall have occurred which could reasonably be expected to have a Material Adverse Effect.

 

ARTICLE
X 

INDEMNIFICATION

 

10.1
Company’s Obligation to Indemnify. In consideration of the Buyers’ execution and delivery of this Agreement,
and in addition to all of the Company’s other obligations under this Agreement, the Company hereby agrees to defend and
indemnify each Buyer and each Buyer’s Affiliates and subsidiaries, and their respective directors, officers, employees,
agents and representatives, and the successors and assigns of each of them (collectively, the “Buyer Indemnified Parties”)
and the Company hereby agrees to hold the Buyer Indemnified Parties harmless, from and against any and all Claims made, brought
or asserted against the Buyer Indemnified Parties, or any one of them, and the Company hereby agrees to pay or reimburse the Buyer
Indemnified Parties for any and all Claims payable by any of the Buyer Indemnified Parties to any Person, including reasonable
attorneys’ and paralegals’ fees and expenses, court costs, settlement amounts, costs of investigation and interest
thereon from the time such amounts are due at the highest non-usurious rate of interest permitted by applicable Law, through all
negotiations, mediations, arbitrations, trial and appellate levels, primarily as a result of, or primarily arising out of or relating
to: (i) any misrepresentation or breach of any representation or warranty made by the Company or any Subsidiaries in this Agreement,
the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby; (ii) any breach of
any covenant, agreement or Obligation of the Company or any Subsidiary contained in this Agreement, the Transaction Documents
or any other certificate, instrument or document contemplated hereby or thereby; or (iii) any Claims brought or made against the
Buyer Indemnified Parties, or any one of them, by any Person and arising out of or resulting from the execution, delivery, performance
or enforcement of this Agreement, the Transaction Documents or any other instrument, document or agreement executed pursuant hereto
or thereto. To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall
make the maximum contribution to the payment and satisfaction of each of the Claims covered hereby, which is permissible under
applicable Law. The Company will not be liable to any Buyer under this indemnity: (i) for any settlement by a Buyer in connection
with any Claim effected without the Company’s prior written consent, which consent shall not be unreasonably withheld, conditioned
or delayed; or (ii) to the extent, but only to the extent, that a Claim is attributable to any Buyer’s breach of any of
the representations, warranties, covenants or agreements made by such Buyer in this Agreement or in the other Transaction Documents.

 

    25

     

    

 

ARTICLE
XI 

MATTERS
RELATING TO THE BUYERS

 

11.1
Independent Nature of Buyers’ Obligations and Rights. The obligations of each Buyer under this Agreement and the
Transaction Documents are several and not joint with the obligations of any other Buyer, and no Buyer shall be responsible in
any way for the performance of the obligations of any other Buyer under any one or more of the Transaction Documents. The decision
of each Buyer to purchase the Shares and the Warrants pursuant to the Transaction Documents has been made by each such Buyer independently
of any other Buyer and independently of any information, materials, statements or opinions as to the business, affairs, operations,
assets, properties, liabilities, results of operations, condition (financial or otherwise) or prospects of the Company or of its
subsidiaries, if any, which may have been made or given by any other Buyer or any of their respective officers, directors, principals,
employees, agents, counsel or representatives (collectively, including the Buyer in question, the “Buyer Representatives”).
No Buyer Representative shall have any liability to any other Buyer or the Company relating to or arising from any such information,
materials, statements or opinions, if any. Each Buyer acknowledges that no other Buyer has acted as agent for such Buyer in connection
with making its investment hereunder and that no Buyer will be acting as agent of such other Buyer in connection with monitoring
its investment in the Securities or enforcing its rights under the Transaction Documents. Each Buyer shall be entitled to independently
protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Buyer to be joined as an additional party in any Proceeding for such purpose.
The Company and each of the Buyers acknowledge that, for reasons of administrative convenience the Company has elected to provide
each of the Buyers with the same Transaction Documents for the purpose of closing a transaction with multiple Buyers and not because
it was required or requested to do so by any Buyer. In furtherance of the foregoing, and not in limitation thereof, the Company
and the Buyers acknowledge that nothing contained in this Agreement or in any Transaction Document, and no action taken by any
Buyer pursuant thereto, shall be deemed to constitute any two or more Buyers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Buyers are in any way acting in concert or as a group with respect
to such obligations or the transactions contemplated by the Transaction Documents.

 

11.2
Equal Treatment of Buyers. No consideration shall be offered or paid to any Buyer to amend or consent to a waiver or modification
of any provision of any of the Transaction Documents, unless the same consideration is also offered to all of the other Buyers
parties to the Transaction Documents.

 

    26

     

    

 

ARTICLE
XII 

TERMINATION

 

12.1
Termination. This Agreement may be terminated prior to Closing (i) by written agreement of the Buyers and the Company,
or (ii) by either the Company or a Buyer (as to itself but no other Buyer) upon written notice to the other, if the Closing shall
not have taken place by October 31, 2019 (the “Termination Date”), provided that (x) the Termination Date may
be extended until November 30, 2019 upon the mutual consent of the Placement Agent and the Company and (y) in the event that there
shall have occurred any material adverse change in the financial markets of the United States, any outbreak or escalation of hostilities
or other national or international calamity or crisis the effect of which is such to make it, in the judgment of the Placement
Agent, impracticable to market the securities offered hereby or enforce contracts for the sale of those securities, the Termination
Date may be unilaterally extended by the Placement Agent for a period not to exceed ninety (90) days from the later of October
31, 2019 or such later date as may have been previously extended by the Placement Agent and the Company pursuant to clause (x)
above (the “Outside Closing Date”).

 

12.2
Consequences of Termination. No termination of this Agreement shall release any party from any liability for breach by
such party of the terms and provisions of this Agreement or the other Transaction Documents.

 

ARTICLE
XIII 

MISCELLANEOUS

 

13.1
Notices. All notices of request, demand and other communications hereunder shall be addressed to the parties as follows:

  

	 	If
    to the Company:	Ondas
    Holdings Inc.
	 	 	165
    Gibraltar Court
	 	 	Sunnyvale,
    CA 94089
	 	 	Attention:
    Chief Executive Officer
	 	 	 
	 	With
    a copy to:	Akerman
    LLP
	 	 	350
    East Las Olas Boulevard, Suite 1600
	 	 	Fort
    Lauderdale, FL 33301
	 	 	Attention:
    Michael Francis; Christina C. Russo
	 	 	 
	 	If
    to the Buyers:	To
    each Buyer based on the information set forth in the Schedule of Buyers attached hereto

 

unless
the address is changed by the party by like notice given to the other parties. Notice shall be in writing and shall be deemed
delivered: (i) if mailed by certified mail, return receipt requested, postage prepaid and properly addressed to the address below,
then three (3) business days after deposit of same in a regularly maintained U.S. Mail receptacle; or (ii) if mailed by Federal
Express, UPS or other nationally recognized overnight courier service, next business morning delivery, then one (1) business day
after deposit of same in a regularly maintained receptacle of such overnight courier; or (iii) if hand delivered, then upon hand
delivery thereof to the address indicated on or prior to 5:00 p.m., New York time, on a business day. Any notice hand delivered
after 5:00 p.m., New York time, shall be deemed delivered on the following business day. Notwithstanding the foregoing, notice,
consents, waivers or other communications referred to in this Agreement may be sent by facsimile, e-mail, or other method of delivery,
but shall be deemed to have been delivered only when the sending party has confirmed (by reply e-mail or some other form of written
confirmation from the receiving party) that the notice has been received by the other party.

 

    27

     

    

 

13.2
Entire Agreement. This Agreement, including the Exhibits and Schedules attached hereto and the documents delivered pursuant
hereto, including the Transaction Documents, set forth all the promises, covenants, agreements, conditions and understandings
between the parties hereto with respect to the subject matter hereof and thereof, and supersede all prior and contemporaneous
agreements, understandings, inducements or conditions, expressed or implied, oral or written, except as contained herein and in
the Transaction Documents; provided, however, except as explicitly stated herein, nothing contained in this Agreement or any other
Transaction Document shall (or shall be deemed to) (i) have any effect on any agreements any Buyer has entered into with, or any
instruments any Buyer has received from, the Company prior to the date hereof with respect to any prior investment made by such
Buyer in the Company or (ii) waive, alter, modify or amend in any respect any obligations of the Company, or any rights of or
benefits to any Buyer or any other Person, in any agreement entered into prior to the date hereof between or among the Company
and any Buyer, or any instruments any Buyer received from the Company prior to the date hereof, and all such agreements and instruments
shall continue in full force and effect..

 

13.3
Successors and Assigns. This Agreement, and any and all rights, duties and obligations hereunder, shall not be assigned,
transferred, delegated or sublicensed by the Company without the prior written consent of each Buyer. Subject to the foregoing
and except as otherwise provided herein, the provisions of this Agreement shall inure to the benefit of, and be binding upon,
the successors, assigns, heirs, executors and administrators of the parties hereto.

 

13.4
Binding Effect. This Agreement shall be binding upon the parties hereto, their respective successors and permitted assigns.

 

13.5
Amendment. Except as specifically set forth herein, neither the Company nor any Buyer makes any representation, warranty,
covenant or undertaking with respect to such matters. For clarification purposes, the Recitals are part of this Agreement. No
provision of this Agreement may be amended other than by an instrument in writing signed by the Company and the Required Buyers.
Any amendment to any provision of this Agreement made in conformity with the provisions of this Section 13.5 shall be binding
on all Buyers and holders of Securities, as applicable, provided that no such amendment shall be effective to the extent that
it (1) applies to less than all of the holders of the Securities then outstanding or (2) imposes any obligation or liability on
any Buyer without such Buyer’s prior written consent (which may be granted or withheld in such Buyer’s sole discretion).
No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party, provided
that the Required Buyers may waive any provision of this Agreement, and any waiver of any provision of this Agreement made in
conformity with the provisions of this Section 13.5 shall be binding on all Buyers and holders of Securities, as applicable,
provided that no such waiver shall be effective to the extent that it (1) applies to less than all of the holders of the Securities
then outstanding (unless a party gives a waiver as to itself only) or (2) imposes any obligation or liability on any Buyer without
such Buyer’s prior written consent (which may be granted or withheld in such Buyer’s sole discretion). No consideration
shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of the Transaction
Documents unless the same consideration also is offered to all of the parties to the Transaction Documents who are holders of
Securities. The Company has not, directly or indirectly, made any agreements with any Buyers relating to the terms or conditions
of the transactions contemplated by the Transaction Documents except as set forth in the Transaction Documents. Without limiting
the foregoing, the Company confirms that, except as set forth in this Agreement, no Buyer has made any commitment or promise or
has any other obligation to provide any financing to the Company or otherwise. As a material inducement for each Buyer to enter
into this Agreement, the Company expressly acknowledges and agrees that no due diligence or other investigation or inquiry conducted
by a Buyer, any of its advisors or any of its representatives shall affect such Buyer’s right to rely on, or shall modify
or qualify in any manner or be an exception to any of, the Company’s representations and warranties contained in this Agreement
or any other Transaction Document. “Required Buyers” means Buyers holding a majority of the Securities sold
pursuant to this Agreement.

 

    28

     

    

 

13.6
Gender and Use of Singular and Plural. All pronouns shall be deemed to refer to the masculine, feminine, neuter, singular
or plural, as the identity of the party or parties or their personal representatives, successors and assigns may require.

 

13.7
Execution. This Agreement may be executed in one or more counterparts, all of which taken together shall be deemed and
considered one and the same Agreement, and same shall become effective when counterparts have been signed by each party and each
party has delivered its signed counterpart to the other party. A digital reproduction, portable document format (“.pdf”)
or other reproduction of this Agreement may be executed by one or more parties hereto and delivered by such party by electronic
signature (including signature via DocuSign or similar services), electronic mail or any similar electronic transmission
device pursuant to which the signature of or on behalf of such party can be seen. Such execution and delivery shall be considered
valid, binding and effective for all purposes.

 

13.8
Headings. The article and section headings contained in this Agreement are inserted for convenience only and shall not
affect in any way the meaning or interpretation of the Agreement.

 

13.9
Governing Law. This Agreement shall be construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Agreement shall be governed by, the internal laws of the State of New York, without
giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that
the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law. In the event that any provision of this Agreement is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Agreement. Nothing
contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the
Company in any other jurisdiction to collect on the Company’s obligations to the Holder, to realize on any collateral or
any other security for such obligations, or to enforce a judgment or other court ruling in favor of the Holder. EACH OF THE PARTIES
HERETO HEREBY IRREVOCABLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    29

     

    

 

13.10
Further Assurances. The parties hereto will execute and deliver such further instruments and do such further acts and things
as may be reasonably required to carry out the intent and purposes of this Agreement.

 

13.11
Survival. The representations and warranties contained herein shall survive the Closing. Each Buyer shall be responsible
only for its own representations, warranties and covenants hereunder.

 

13.12
Joint Preparation. The preparation of this Agreement has been a joint effort of the parties and the resulting documents
shall not, solely as a matter of judicial construction, be construed more severely against one of the parties than the other.

 

13.13
Severability. If any one of the provisions contained in this Agreement, for any reason, shall be held invalid, illegal
or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision of this
Agreement, and this Agreement shall remain in full force and effect and be construed as if the invalid, illegal or unenforceable
provision had never been contained herein.

 

13.14
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

13.15
WAIVER OF JURY TRIAL. THE BUYERS AND THE COMPANY, AFTER CONSULTING OR HAVING HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL,
EACH KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES, IRREVOCABLY, THE RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LEGAL PROCEEDING
BASED HEREON, OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT OR ANY OTHER AGREEMENT
EXECUTED OR CONTEMPLATED TO BE EXECUTED IN CONJUNCTION WITH THIS AGREEMENT, OR ANY COURSE OF CONDUCT OR COURSE OF DEALING IN WHICH
THE BUYERS AND THE COMPANY ARE ADVERSE PARTIES. THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE BUYERS TO PURCHASE THE SHARES
AND THE WARRANTS.

  

[SIGNATURES
ON THE FOLLOWING PAGE]

 

    30

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date and year set forth above.

 

	 	“COMPANY”
	 	 
	 	ONDAS
    HOLDINGS INC.,
	 	a
    Nevada corporation
	 	 
	 	By:	
	 	 	Eric
    Brock,
	 	 	Chief
    Executive Officer
	 	 	 
	 	BUYERS:
	 	See Signature pages for each Buyer attached

 

 Company Signature Page to Securities Purchase Agreement

 

     

     

    

 

BUYER
SIGNATURE PAGE FOR SECURITIES PURCHASE AGREEMENT

 

WITH
ONDAS HOLDINGS INC.

 

By
its execution below, the undersigned Buyer hereby acknowledges and agrees to the terms set forth in the Securities Purchase Agreement
to which this signature page is attached.

 

	FOR
        ENTITY INVESTORS:

          

        

        Name of Entity:_______________________

          

        By:_____________________________________

        Name:___________________________________

        Title:____________________________________ 
	FOR
        INDIVIDUAL INVESTORS:

          

        Signature: ______________________________

        Name:  _________________________________

         

        

Signature:  ______________________________

        Name:
_________________________________

	 	 
	WORK
        ADDRESS:

         

        ________________________________________

         

        ________________________________________

         

        Attention:  _______________________________

         

        Phone:  __________________________________

         

        Fax:  ____________________________________

         

        E-mail:  __________________________________

         

        Taxpayer
ID#:  _______________________________
	HOME
        ADDRESS:

         

        ________________________________________

         

        ________________________________________

         

        Phone: _____________________

         

        SSN:  _______________________

         

 

 

Aggregate
Purchase Price for Buyer’s Units: $_________________

 

 Buyer Signature Page to Securities Purchase Agreement

 

     

     

    

 

BUYER
ADDENDUM RE ESCROW

(this
information is required)

  

______________________________

(Print
Name of Buyer)

 

By
signing the Securities Purchase Agreement, the above named Buyer hereby certifies and confirms that: In the event that the Escrow
Agent makes a disbursement to the Buyer, which may or may not occur, the Buyer hereby confirms that such disbursement is to be
made by wire transfer using the following wire transfer instructions. The Escrow Agent, the Company and the Placement Agent can
rely on this confirmation and the Buyer will not revoke this confirmation unless the Buyer confirms to the Company on this form,
replacement wire transfer instructions at least two (2) Business Days before revoking this confirmation. The Company may instruct
the Escrow Agent to, or the Escrow Agent may on its own, withhold any such disbursement until the Company is reasonably satisfied
and the Escrow Agent is satisfied in its sole discretion with the instructions and procedures for making such disbursement.

 

 

Bank
Name: ____________________

 

Bank
Address: ____________________

 

ABA
Number: ____________________

 

Account
Number: ____________________

 

Account
Name: ____________________

 

Reference:
____________________

 

 

Escrow Addendum

 

     

     

    

 

EXHIBIT
A

 

Registration
Rights Agreement

 

(Omitted
and Filed as Exhibit 10.2 to Form 8-K)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    A-1

     

    

 

EXHIBIT
B

 

WARRANT

  

(Omitted
and Filed as Exhibit 4.1 to Form 8-K)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    B-1

     

    

 

EXHIBIT
C

 

ESCROW
DEPOSIT AGREEMENT

 

This
ESCROW DEPOSIT AGREEMENT (this “Agreement”) dated as of this ___ day of September __2019, by and among
ONDAS HOLDINGS INC. a Nevada Corporation (the “Company”), having an address at 165 Gibraltar Court,
Sunnyvale, CA 94089, NATIONAL SECURITIES CORPORATION (the “Placement Agent”), having an address at 200
Vesey Street, 25th Floor, New York, NY, and SIGNATURE BANK (the “Escrow Agent”), a New York
State chartered bank, having an office at 261 Madison Avenue, New York, NY 10016. All capitalized terms not herein defined shall
have the meaning ascribed to them in that certain Securities Purchase Agreement to be entered into by and among the Company and
the Investors named therein, including all attachments, schedules and exhibits thereto (the “Agreement”).

 

W
I T N E S S E T H:

 

WHEREAS,
pursuant to the terms of the Agreement, the Company desires to sell (the “Offering”) a minimum of $5,000,000
(the “Minimum Amount”) and a maximum of $12,500,000 (including an over-allotment option exercisable by the
Placement Agent for the Company to sell up to an additional $2,500,00 of Units (as defined below) (the “Maximum Amount”),
of its offering units (the “Units”), each consisting of a share of the Company’s common stock, par value
$0.0001 per share (the “Common Stock”), and one-half of one warrant exercisable in shares of Common Stock (the
“Warrant”). Each Unit is being sold at a price of $2.50 per Unit; and

 

WHEREAS,
unless the Minimum Amount is sold by October 31, 2019 (the “Termination Date”), or by November 30, 2019
(the “Final Termination Date”) if the Termination Date has been extended by Company and the Placement Agent,
the Offering shall terminate and all funds shall be returned to the subscribers in the Offering; and if the Minimum Amount is
met by the Termination Date or Final Termination Date (if extended), the Offering may continue until the earlier of (i) the Termination
Date or Final Termination Date (if extended); and

 

WHEREAS,
the Company and Placement Agent desire to establish an escrow account with the Escrow Agent into which the Company and Placement
Agent shall instruct subscribers introduced to the Company by Placement Agent (the “Subscribers”) to deposit
checks and other instruments for the payment of money made payable to the order of “Signature Bank as Escrow Agent for Ondas
Holdings Inc.” and Escrow Agent is willing to accept said checks and other instruments for the payment of money in accordance
with the terms hereinafter set forth; and

 

WHEREAS,
the Company, as issuer, and Placement Agent, as an introducing broker-dealer, represent and warrant to the Escrow Agent that they
will comply with all of their respective obligations under applicable state and federal securities laws and regulations with respect
to the sale of Units pursuant to the Offering; and

 

WHEREAS,
the Company and Placement Agent represent and warrant to the Escrow Agent that they have not stated to any individual or entity
that the Escrow Agent’s duties will include anything other than those duties stated in this Agreement; and

 

WHEREAS,
the Company and Placement Agent represent and warrant to the Escrow Agent that a copy of each document that has been delivered
to Subscribers and third parties that include Escrow Agent’s name and duties is attached hereto as Schedule I.

 

    C-1

     

    

 

NOW,
THEREFORE, IT IS AGREED as follows:

 

1.
Delivery of Escrow Funds.

 

(a)
The Placement Agent and the Company shall instruct Subscribers to deliver to Escrow Agent checks made payable to the order of
“Signature Bank, as Escrow Agent for Ondas Holdings Inc.” or wire transfer to Signature Bank, 261 Madison Avenue,
New York, NY 10016, ABA No. 026013576 for credit to Signature Bank, as Escrow Agent for Ondas Holdings Inc., Account No. 1503[______],
in each case, with the name and address of the individual or entity making payment. In the event any Subscriber’s address
is not provided to Escrow Agent by the Subscriber, then the Company agrees to promptly provide Escrow Agent with such information
in writing. The checks or wire transfers shall be deposited into a non-interest-bearing account at Signature Bank entitled “Ondas
Holdings Inc., Signature Bank, as Escrow Agent” (the “Escrow Account”).

 

(b)
The collected funds deposited into the Escrow Account are referred to as the “Escrow Funds.”

 

(c)
The Escrow Agent shall have no duty or responsibility to enforce the collection or demand payment of any funds deposited into
the Escrow Account. If, for any reason, any check deposited into the Escrow Account shall be returned unpaid to the Escrow Agent,
the sole duty of the Escrow Agent shall be to return the check to the Subscriber and advise the Company and Placement Agent promptly
thereof.

 

2.
Release of Escrow Funds. The Escrow Funds shall be paid by the Escrow Agent in accordance with the following:

 

(a)
In the event that the Company and Placement Agent advise the Escrow Agent in writing that the Offering has been terminated (the
“Termination Notice”), the Escrow Agent shall promptly return the funds paid by each Subscriber to said Subscriber
without interest or offset.

 

(b)
If prior to 3:00 P.M. Eastern time on the Termination Date, the Escrow Agent receives written notice, in the form of Exhibit
A, attached hereto and made a part hereof, and signed by the Company and Placement Agent, stating that the Termination Date has
been extended to the Final Termination Date (the “Extension Notice”), then the Termination Date shall be so
extended. 

 

(c)
Provided that the Escrow Agent does not receive the Termination Notice in accordance with Section 2(a) and the Minimum Amount
has been deposited into the Escrow Account on or prior to the later of the Termination Date or the date stated in the Extension
Notice, if any, received by the Escrow Agent in accordance with Section 2(b) above, the Escrow Agent shall, upon receipt of written
instructions, in the form of Exhibit B, attached hereto and made a part hereof, or in a form and substance satisfactory to the
Escrow Agent, received from the Company and Placement Agent, pay the Escrow Funds in accordance with such written instructions,
which instructions shall be limited to the payment of the Placement Agent’s fee and other offering expenses and the payment
of the balance to the Company (each, the “Closing”). Such payment or payments shall be made by wire transfer
within one (1) Business Day of receipt of such written instructions, which must be received by the Escrow Agent no later than
3:00 PM Eastern Time on a Business Day for the Escrow Agent to process such instructions that Business Day. The Company and the
Placement Agent further agree that there shall be a limit of one (1) Closing under this Agreement with the Closing limited to
four (4) wires. Any additional wires may be subject to additional fees.

 

    C-2

     

    

 

(d)
If by 3:00 P.M. Eastern time on the later of the Termination Date or the date stated in the Extension Notice, if any, that the
Escrow Agent has received in accordance with Section 2(b) above, the Escrow Agent has not received written instructions from the
Company and Placement Agent regarding the disbursement of the Escrow Funds or the total amount of the Escrow Funds is less than
the Minimum Amount, then the Escrow Agent shall promptly return the Escrow Funds to the Subscribers without interest or offset
and close the Escrow Account immediately thereafter. The Escrow Funds returned to each Subscriber shall be free and clear of any
and all claims of the Escrow Agent.

 

(e)
The Escrow Agent shall not be required to pay any uncollected funds or any funds that are not available for withdrawal. Should
any party to this Agreement be a non-U.S. entity, the Escrow Agent may require up to an additional five (5) Business Days to open
the Escrow Account.

 

(f)
If the Termination Date, Final Termination Date or any date that is a deadline under this Agreement for giving the Escrow Agent
notice or instructions or for the Escrow Agent to take action is not a Business Day, then such date shall be the Business Day
that immediately precedes that date. A “Business Day” is any day other than a Saturday, Sunday or a Bank holiday.

 

3.
Acceptance by Escrow Agent. The Escrow Agent hereby accepts and agrees to perform its obligations hereunder, provided that:

  

(a)
Upon execution of this Agreement, the Company shall execute and deliver to Escrow Agent Exhibit C hereto and the Placement Agent
shall execute and deliver to Escrow Agent Exhibit C-1 hereto (together with Exhibit C, each a “Certificate”),
for the purpose of (i) establishing the identity of each respective authorized representative(s) of the Company and the Placement
Agent entitled to singly initiate and/or confirm disbursement instructions to Escrow Agent on behalf of each such party and (ii)
providing standing wire instructions for each of the Company and Placement Agent to be used for disbursements to said party. The
Escrow Agent may act in reliance upon any signature on each Certificate believed by it to be genuine, and may assume that any
person who has been designated by Placement Agent or the Company to give any written instructions, notice or receipt, or make
any statements in connection with the provisions hereof has been duly authorized to do so. The Escrow Agent shall have no duty
to make inquiry as to the genuineness, accuracy or validity of any statements or instructions or any signatures on statements
or instructions, including but not limited to, those contained on each Certificate. The Company and the Placement Agent may update
their respective Certificate by executing and delivering to the Escrow Agent an updated Certificate substantially in the form
attached hereto as Exhibit C and/or Exhibit C-1. Until such time as Escrow Agent shall receive an updated Certificate, Escrow
Agent shall be fully protected in relying without inquiry on the current Certificate on file with Escrow Agent.

  

(b)
The Escrow Agent may seek confirmation of disbursement instructions by telephone call back to one of the authorized representatives
set forth on each Certificate, and the Escrow Agent may rely upon the confirmations of anyone purporting to be the person(s)
so designated. To ensure the accuracy of the instruction it receives, the Escrow Agent may record such call back. If the Escrow
Agent is unable to verify the instruction, or is not satisfied in its sole discretion with the verification it receives, it will
not execute the instruction until all issues have been resolved to its satisfaction. The Company and Placement Agent agree that
the foregoing procedures constitute commercially reasonable security procedures. Escrow Agent further agrees not to comply with
any direction or instruction (other than those contained herein or delivered in accordance with this Agreement) from any party
inconsistent with the foregoing.

 

    C-3

     

    

 

(c)
The Escrow Agent may act relative hereto in reliance upon advice of counsel in reference to any matter connected herewith. The
Escrow Agent shall not be liable for any mistake of fact or error of judgment or law, or for any acts or omissions of any kind,
unless caused by its willful misconduct or gross negligence.

 

(d)
The Placement Agent and the Company agree to indemnify and hold the Escrow Agent harmless from and against any and all claims,
losses, costs, liabilities, damages, suits, demands, judgments or expenses (including but not limited to reasonable attorney’s
fees) claimed against or incurred by Escrow Agent arising out of or related, directly or indirectly, to this Escrow Agreement
unless caused by the Escrow Agent’s gross negligence or willful misconduct.

 

(e)
In the event that the Escrow Agent shall be uncertain as to its duties or rights hereunder, the Escrow Agent shall be entitled
to (i) refrain from taking any action other than to keep safely the Escrow Funds until it shall be directed otherwise by a court
of competent jurisdiction, or (ii) deliver the Escrow Funds to a court of competent jurisdiction.

 

(f)
The Escrow Agent shall have no duty, responsibility or obligation to interpret or enforce the terms of any agreement other than
Escrow Agent’s obligations hereunder, and the Escrow Agent shall not be required to make a request that any monies be delivered
to the Escrow Account, it being agreed that the sole duties and responsibilities of the Escrow Agent shall be to the extent not
prohibited by applicable law (i) to accept checks or other instruments for the payment of money and wire transfers delivered to
the Escrow Agent for the Escrow Account and deposit said checks and wire transfers into the non-interest bearing Escrow Account,
and (ii) to disburse or refrain from disbursing the Escrow Funds as stated above, provided that the checks received by the Escrow
Agent have been collected and are available for withdrawal.

 

4.
Escrow Account Statements and Information. The Escrow Agent agrees to send to the Company and/or the Placement Agent a
copy of the Escrow Account periodic statement, upon request in accordance with the Escrow Agent’s regular practices for
providing account statements to its non-escrow clients, and to also provide the Company and/or Placement Agent, or their designee,
upon request other deposit account information, including Escrow Account balances, by telephone or by computer communication,
to the extent practicable. The Company and Placement Agent agree to complete and sign all forms or agreements required by the
Escrow Agent for that purpose. The Company and Placement Agent each consents to the Escrow Agent’s release of such Escrow
Account information to any of the individuals designated by Company or Placement Agent, which designation has been signed in accordance
with Section 3(a) by any of the persons on the Company and Placement Agent’s respective Certificate. Further, the Company
and Placement Agent have an option to receive e-mail notification of incoming and outgoing wire transfers. If this e-mail notification
service is requested and subsequently approved by the Escrow Agent, the Company and/or Placement Agent agrees to provide a valid
e-mail address and other information necessary to set-up this service and sign all forms and agreements required for such service.
The Company and Placement Agent each consents to the Escrow Agent’s release of wire transfer information to the designated
e-mail address(es). The Escrow Agent’s liability for failure to comply with this section shall not exceed the cost of providing
such information.

 

    C-4

     

    

 

5.
Resignation and Termination of the Escrow Agent. The Escrow Agent may resign at any time by giving thirty (30) days’
prior written notice of such resignation to the Placement Agent and the Company. Upon providing such notice, the Escrow Agent
shall have no further obligation hereunder except to hold as depository the Escrow Funds that it receives until the end of such
thirty (30)-day period. In such event, the Escrow Agent shall not take any action, other than receiving and depositing Subscribers
checks and wire transfers in accordance with this Agreement, until the Company has designated a banking corporation, trust company,
attorney or other person as successor. Upon receipt of such written designation signed by Placement Agent and the Company, the
Escrow Agent shall promptly deliver the Escrow Funds to such successor and shall thereafter have no further obligations hereunder.
If such instructions are not received within thirty (30) days following the effective date of such resignation, then the Escrow
Agent may (i) deposit the Escrow Funds held by it pursuant to this Agreement with a clerk of a court of competent jurisdiction
pending the appointment of a successor; or (ii) return all funds remaining in the Escrow Account to the Subscribers in the Offering,
in the same manner as such funds were received (and Company and Placement Agent agree to cooperate with Escrow Agent in providing
any information required to facilitate such a return of funds to the Subscribers). In either case provided for in this section,
the Escrow Agent shall be relieved of all further obligations and released from all liability thereafter arising with respect
to the Escrow Funds.

 

6.
Termination. The Company and Placement Agent may terminate the appointment of the Escrow Agent hereunder upon written notice
specifying the date upon which such termination shall take effect, which date shall be at least thirty (30) days from the date
of such notice. In the event of such termination, the Company and Placement Agent shall, within thirty (30) days of such notice,
appoint a successor escrow agent and the Escrow Agent shall, upon receipt of written instructions signed by the Company and Placement
Agent, turn over to such successor escrow agent all of the Escrow Funds; provided, however, that if the Company
and Placement Agent fail to appoint a successor escrow agent within such thirty (30) day period, such termination notice shall
be null and void and the Escrow Agent shall continue to be bound by all of the provisions hereof. Upon receipt of the Escrow Funds,
the successor escrow agent shall become the escrow agent hereunder and shall be bound by all of the provisions hereof and Escrow
Agent shall be relieved of all further obligations and released from all liability thereafter arising with respect to the Escrow
Funds and under this Agreement.

 

7.
Investment. All funds received by the Escrow Agent shall be held only in non-interest bearing bank accounts at Escrow Agent.

 

8.
Compensation. The Escrow Agent shall be entitled, for the duties to be performed by it hereunder, to a fee of $4,000.00,
which fee shall be paid by the Company upon the signing of this Agreement. In addition, the Company shall be obligated to reimburse
Escrow Agent for all fees, costs and expenses incurred or that become due in connection with this Agreement or the Escrow Account,
including reasonable attorneys’ fees. Neither the modification, cancellation, termination or rescission of this Agreement
nor the resignation or termination of the Escrow Agent shall affect the right of the Escrow Agent to retain the amount of any
fee which has been paid, or to be reimbursed or paid any amount which has been incurred or becomes due, prior to the effective
date of any such modification, cancellation, termination, resignation or rescission. To the extent the Escrow Agent has incurred
any such expenses, or any such fee becomes due, prior to the Closing, the Escrow Agent shall advise the Company and the Company
shall direct all such amounts to be paid directly the Closing.

 

9.
Notices. All notices, requests, demands and other communications required or permitted to be given hereunder shall be in
writing and shall be deemed to have been duly given if sent by hand-delivery, by facsimile (followed by first-class mail), by
nationally recognized overnight courier service or by prepaid registered or certified mail, return receipt requested, to the addresses
set forth below:

 

If
to Placement Agent:

National
Securities Corporation

200
Vesey Street, 25th Floor

New
York, NY 10281

Attention:
Jonathan C. Rich, Executive Vice President and Head of Investment Banking

Fax:
212-380-2828 

 

    C-5

     

    

 

If
to the Company:

Ondas
Holdings Inc.

165
Gibraltar Court

Sunnyvale,
CA 94089

Attention:
Eric A. Brock, Chairman and Chief Executive Officer

 

If
to Escrow Agent:

261
Madison Avenue

New
York, New York 10016

Attention:
Cliff Broder, Group Director & Senior Vice President

Fax:
(646) 758-8413

  

10.
General.

 

(a)
This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York applicable
to agreements made and to be entirely performed within such State, without regard to choice of law principles, and any action
brought hereunder shall be brought in the courts of the State of New York, located in the County of New York. Each party hereto
irrevocably waives any objection on the grounds of venue, forum nonconveniens or any similar grounds and irrevocably consents
to service of process by mail or in any manner permitted by applicable law and consents to the jurisdiction of said courts. EACH
OF THE PARTIES HERETO HEREBY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF THE TRANSACTIONS
CONTEMPLATED BY THIS AGREEMENT.

 

(b)
This Agreement sets forth the entire agreement and understanding of the parties with respect to the matters contained herein and
supersedes all prior agreements, arrangements and understandings relating thereto.

 

(c)
All of the terms and conditions of this Agreement shall be binding upon, and inure to the benefit of and be enforceable by, the
parties hereto, as well as their respective successors and assigns.

 

(d)
This Agreement may be amended, modified, superseded or canceled, and any of the terms or conditions hereof may be waived, only
by a written instrument executed by each party hereto or, in the case of a waiver, by the party waiving compliance. The failure
of any party at any time or times to require performance of any provision hereof shall in no manner affect its right at a later
time to enforce the same. No waiver of any party of any condition, or of the breach of any term contained in this Agreement, whether
by conduct or otherwise, in any one or more instances shall be deemed to be or construed as a further or continuing waiver of
any such condition or breach or a waiver of any other condition or of the breach of any other term of this Agreement. No party
may assign any rights, duties or obligations hereunder unless all other parties have given their prior written consent.

 

(e)
If any provision included in this Agreement proves to be invalid or unenforceable, it shall not affect the validity of the remaining
provisions.

 

(f)
This Agreement and any modification or amendment of this Agreement may be executed in several counterparts or by separate instruments
and all of such counterparts and instruments shall constitute one agreement, binding on all of the parties hereto.

 

11.
Form of Signature. The parties hereto agree to accept a facsimile transmission copy of their respective actual signatures
as evidence of their actual signatures to this Agreement and any modification or amendment of this Agreement; provided,
however, that each party who produces a facsimile signature agrees, by the express terms hereof, to place, promptly after
transmission of his or her signature by fax, a true and correct original copy of his or her signature in overnight mail to the
address of the other party.

 

12.
No Third-Party Beneficiaries. This Agreement is solely for the benefit of the parties and their respective successors and
permitted assigns, and no other person has any right, benefit, priority, or interest under or because of the existence of this
Agreement.

 

    C-6

     

    

 

IN
WITNESS WHEREOF, the parties have duly executed this Agreement as of the date first set forth above.

  

ONDAS
HOLDINGS INC.

  

	By:		 

 

Name:
Eric A. Brock

Title:
Chairman and Chief Executive Officer

 

NATIONAL
SECURITIES CORPORATION

 

	By:		 

Name:
Jonathan Rich

Title:
EVP, Head of Investment Banking

 

SIGNATURE
BANK

 

	By:		 

Name:
Cliff Broder

Title:
Group Director & Senior Vice President

 

	By:		 

Name:

Title:

 

    C-7

     

    

 

Schedule
I

 

OFFERING
DOCUMENTS

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    C-8

     

    

 

Exhibit
A

 

EXTENSION
NOTICE

 

Date:
[___________] __, 2019

 

Signature
Bank

261
Madison Avenue

New
York, New York 10016

Attention:
Cliff Broder, Group Director & Senior Vice President

  

Dear
Mr. Broder:

 

In
accordance with the terms of Section 2(b) of an Escrow Deposit Agreement dated as of September [__], 2019 (the "Escrow
Agreement"), by and between Ondas Holdings Inc. (the "Company"), National Securities Corporation (the
"Placement Agent"), and Signature Bank (the "Escrow Agent"), the Company and Placement Agent
hereby notifies the Escrow Agent that the Termination Date has been extended to November 30, 2019, the Final Termination Date.

 

Very
truly yours,

 

ONDAS
HOLDINGS INC.

 

	By:		 

Name:    Eric
A. Brock

Title:      Chairman
and Chief Executive Officer

 

NATIONAL
SECURITIES CORPORATION

 

	By:		 

Name:    Jonathan
C. Rich

Title:      EVP,
Head of Investment Banking

 

    C-9

     

    

 

Exhibit
B

 

FORM
OF ESCROW RELEASE NOTICE

 

Date:
[___________] __, 2019

 

Signature
Bank

261
Madison Avenue

New
York, New York 10016

Attention:
Cliff Broder, Group Director & Senior Vice President

  

Dear
Mr. Broder:

 

1.1
In accordance with the terms of Section 2(c) of an Escrow Deposit Agreement dated as of September [__], 2019 (the "Escrow
Agreement"), by and between Ondas Holdings Inc. (the "Company"), National Securities Corporation (the
"Placement Agent"), and Signature Bank (the "Escrow Agent"), the Company and Placement Agent
hereby notify the Escrow Agent that the ________ closing will be held on ___________ for gross proceeds of $_________.

 

	 	1.1.1	PLEASE DISTRIBUTE FUNDS BY WIRE TRANSFER AS
    FOLLOWS (wire instructions attached):

 

Ondas
Holdings Inc.:                                                                              $

 

National
Securities Corporation:                                 $

 

Very
truly yours,

 

ONDAS
HOLDINGS INC.

 

	By:		 

Name:    Eric
A. Brock

Title:      Chairman
and Chief Executive Officer

 

NATIONAL
SECURITIES CORPORATION

 

	By:		 

Name:    Jonathan
C. Rich

Title:      EVP,
Head of Investment Banking

 

    C-10

     

    

 

EXHIBIT
C

 

CERTIFICATE
OF AUTHORIZED REPRESENTATIVES – COMPANY

  

	Name	 	Signature	 	Initiate
    (Y/N)	 	Callback

        (Y/N)
	 	Phone
    No.	 	Alt.
    Phone No.
	 

        ______________
	 	 

        ______________
	 	 

        ______
	 	 

        _______
	 	 

        ________________
	 	 

        ________________

	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 
	 

        ______________
	 	 

        _______________
	 	 

        ______
	 	 

        _______
	 	 

        ________________
	 	 

        ________________

	 

        ______________
	 	 

        ______________
	 	 

        ______
	 	 

        _______
	 	 

        ________________
	 	 

        ________________

 

 

 

 

 

 

 

STANDING
WIRE INSTRUCTIONS FOR COMPANY

 

In
accordance with Section 3(a) of the Agreement disbursements to Company by wire transfer must be sent in accordance with the following
wire instructions:

 

Bank Name:               
   

Bank Address:           
   

 

ABA Number:            
    

Account Number:            

Account Name:             
  

 

    C-11

     

    

 

EXHIBIT
C-1

 

CERTIFICATE
OF AUTHORIZED REPRESENTATIVES – PLACEMENT AGENT

 

	Name	 	Signature	 	Initiate
    (Y/N)	 	Callback

        (Y/N)
	 	Phone
    No.	 	Alt.
    Phone No.
	 

        ______________
	 	 

        ______________
	 	 

        ______
	 	 

        _______
	 	 

        ________________
	 	 

        ________________

	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 
	 

        ______________
	 	 

        ________________
	 	 

        ______
	 	 

        _______
	 	 

        ________________
	 	 

        ________________

	 

        ______________
	 	 

        ______________
	 	 

        ______
	 	 

        _______
	 	 

        ________________
	 	 

        ________________

 

 

 

 

  

 

STANDING
WIRE INSTRUCTIONS FOR PLACEMENT AGENT

 

In
accordance with Section 3(a) of the Agreement disbursements to Placement Agent by wire transfer must be sent in accordance with
the following wire instructions:

  

Bank
Name:

Bank
Address:

 

ABA
Number:

Account
Number:

Account
Name:

 

    C-12

     

    

 

EXHIBIT
D 

 

 LOCK
UP AGREEMENT

 

 (Omitted
and Filed as Exhibit 10.3 to Form 8-K)

 

 

 

 

 

 

 

    D-1

     

    

  

EXHIBIT
E

 

PARTIES
TO LOCKUP AGREEMENTS

  

	1.	Eric A. Brock

 

	2.	Stewart Kantor

 

	3.	Richard M. Cohen

 

	4.	Richard H. Silverman

 

	5.	Derek Reisfield

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

E-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]